Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Tuberculosis

  Free Subscription


Articles published in Int J Tuberc Lung Dis

Retrieve available abstracts of 581 articles:
HTML format
Text format



Single Articles


    April 2017
  1. JAIN A, Singh PK, Singh U, Kumar V, et al
    Initial screening of extra-pulmonary tuberculosis using the Xpert MTB/RIF assay improves case detection rates.
    Int J Tuberc Lung Dis. 2017;21:478-480.
    PubMed     Text format    


  2. CHONG SG, Herron M, Dorman A, Little M, et al
    Renal amyloidosis complicating multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:476-477.
    PubMed     Text format    


  3. BLOK L, Bakker MI, Straetemans M, Gerstel L, et al
    Should active case-finding projects increase the number of tuberculosis cases notified at national level?
    Int J Tuberc Lung Dis. 2017;21:475.
    PubMed     Text format    


  4. WEBER SF, Belard S, Rai S, Reddy R, et al
    Immune thrombocytopenia secondary to tuberculosis: a case and review of literature.
    Int J Tuberc Lung Dis. 2017;21:466-470.
    PubMed     Text format     Abstract available


  5. VALENCIA S, Respeito D, Blanco S, Ribeiro RM, et al
    Tuberculosis drug resistance in Southern Mozambique: results of a population-level survey in the district of Manhica.
    Int J Tuberc Lung Dis. 2017;21:446-451.
    PubMed     Text format     Abstract available


  6. ADLER H, Archary M, Mahabeer P, LaRussa P, et al
    Tuberculosis in HIV-infected South African children with complicated severe acute malnutrition.
    Int J Tuberc Lung Dis. 2017;21:438-445.
    PubMed     Text format     Abstract available


  7. CARTER KL, Gabrellas AD, Shah S, Garland JM, et al
    Improved latent tuberculosis therapy completion rates in refugee patients through use of a clinical pharmacist.
    Int J Tuberc Lung Dis. 2017;21:432-437.
    PubMed     Text format     Abstract available


  8. ARMENTA RF, Collins KM, Strathdee SA, Bulterys MA, et al
    Mycobacterium tuberculosis infection among persons who inject drugs in San Diego, California.
    Int J Tuberc Lung Dis. 2017;21:425-431.
    PubMed     Text format     Abstract available


  9. SHAIKH N, Gupte A, Dharmshale S, Pokkali S, et al
    Novel interferon-gamma assays for diagnosing tuberculosis in young children in India.
    Int J Tuberc Lung Dis. 2017;21:412-419.
    PubMed     Text format     Abstract available


  10. VAN WYK SS, Lin HH, Claassens MM
    A systematic review of prediction models for prevalent pulmonary tuberculosis in adults.
    Int J Tuberc Lung Dis. 2017;21:405-411.
    PubMed     Text format     Abstract available


  11. OWUSU-EDUSEI K, Marks SM, Miramontes R, Stockbridge EL, et al
    Tuberculosis hospitalization expenditures per patient from private health insurance claims data, 2010-2014.
    Int J Tuberc Lung Dis. 2017;21:398-404.
    PubMed     Text format     Abstract available


  12. RUPERT S, Vassall A, Raizada N, Khaparde SD, et al
    Bottom-up or top-down: unit cost estimation of tuberculosis diagnostic tests in India.
    Int J Tuberc Lung Dis. 2017;21:375-380.
    PubMed     Text format     Abstract available


  13. PANDEY S, Chadha VK, Laxminarayan R, Arinaminpathy N, et al
    Estimating tuberculosis incidence from primary survey data: a mathematical modeling approach.
    Int J Tuberc Lung Dis. 2017;21:366-374.
    PubMed     Text format     Abstract available


  14. DODD PJ
    Tracking tuberculosis incidence: time to tool up.
    Int J Tuberc Lung Dis. 2017;21:363.
    PubMed     Text format    


    March 2017
  15. ZHANG ZX, Sng LH, Yong Y, Lin LM, et al
    Delays in diagnosis and treatment of pulmonary tuberculosis in AFB smear-negative patients with pneumonia.
    Int J Tuberc Lung Dis. 2017 Mar 16. doi: 10.5588/ijtld.16.0667.
    PubMed     Text format     Abstract available


  16. MASJEDI MR, Hosseini M, Aryanpur M, Mortaz E, et al
    The effects of smoking on treatment outcome in patients newly diagnosed with pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:351-356.
    PubMed     Text format     Abstract available


  17. BOONYAGARS L, Hirunwiwatkul P, Hurst CP
    CD4 count and risk of anti-tuberculosis drug-associated cutaneous reactions in HIV-infected Thai patients.
    Int J Tuberc Lung Dis. 2017;21:338-344.
    PubMed     Text format     Abstract available


  18. DIAS M, Gaio R, Sousa P, Abranches M, et al
    Tuberculosis among the homeless: should we change the strategy?
    Int J Tuberc Lung Dis. 2017;21:327-332.
    PubMed     Text format     Abstract available


  19. O'HARA LM, Yassi A, Bryce EA, van Rensburg AJ, et al
    Infection control and tuberculosis in health care workers: an assessment of 28 hospitals in South Africa.
    Int J Tuberc Lung Dis. 2017;21:320-326.
    PubMed     Text format     Abstract available


  20. HUERGA H, Bastard M, Kamene M, Wanjala S, et al
    Outcomes from the first multidrug-resistant tuberculosis programme in Kenya.
    Int J Tuberc Lung Dis. 2017;21:314-319.
    PubMed     Text format     Abstract available


  21. JAVAID A, Hasan R, Zafar A, Chaudry MA, et al
    Pattern of first- and second-line drug resistance among pulmonary tuberculosis retreatment cases in Pakistan.
    Int J Tuberc Lung Dis. 2017;21:303-308.
    PubMed     Text format     Abstract available


  22. FOX GJ, Anh NT, Nhung NV, Loi NT, et al
    Latent tuberculous infection in household contacts of multidrug-resistant and newly diagnosed tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:297-302.
    PubMed     Text format     Abstract available


  23. KAMAKIA R, Kiazyk S, Waruk J, Meyers A, et al
    Potential biomarkers associated with discrimination between latent and active pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:278-285.
    PubMed     Text format     Abstract available


  24. NAUSCH N, Lundtoft C, Schulz G, Henckel H, et al
    Multiple cytokines for the detection of Mycobacterium tuberculosis infection in children with tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:270-277.
    PubMed     Text format     Abstract available


  25. DONNAN EJ, Coulter C, Simpson G, Clark J, et al
    Paediatric tuberculosis in Queensland, Australia: overrepresentation of cross-border and Indigenous children.
    Int J Tuberc Lung Dis. 2017;21:263-269.
    PubMed     Text format     Abstract available


  26. CRANMER LM, Langat A, Ronen K, McGrath CJ, et al
    Integrating tuberculosis screening in Kenyan Prevention of Mother-To-Child Transmission programs.
    Int J Tuberc Lung Dis. 2017;21:256-262.
    PubMed     Text format     Abstract available


  27. REICHMAN LB
    The tuberculosis taboo.
    Int J Tuberc Lung Dis. 2017;21:251-255.
    PubMed     Text format     Abstract available


    February 2017
  28. PRIYADARSHINI P, Tiwari K, Das A, Kumar D, et al
    Evaluation of highly conserved hsp65-specific nested PCR primers for diagnosing Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:214-217.
    PubMed     Text format     Abstract available


  29. MCEBULA V, Crowther NJ, Nagel SE, George JA, et al
    Diabetes and abnormal glucose tolerance in subjects with tuberculosis in a South African urban center.
    Int J Tuberc Lung Dis. 2017;21:208-213.
    PubMed     Text format     Abstract available


  30. BRYLA M, Dziankowska-Zaborszczyk E, Maniecka-Bryla I
    Standard expected years of life lost due to tuberculosis in Poland.
    Int J Tuberc Lung Dis. 2017;21:202-207.
    PubMed     Text format     Abstract available


  31. CLAASSENS MM, Dunbar R, Yang B, Lombard CJ, et al
    Scanty smears associated with initial loss to follow-up in South African tuberculosis patients.
    Int J Tuberc Lung Dis. 2017;21:196-201.
    PubMed     Text format     Abstract available


  32. IZUMI K, Ohkado A, Uchimura K, Kawatsu L, et al
    Evaluation of tuberculosis contact investigations in Japan.
    Int J Tuberc Lung Dis. 2017;21:188-195.
    PubMed     Text format     Abstract available


  33. HTET KK, Liabsuetrakul T, Thein S
    Cost-effectiveness of a new strategy to detect pulmonary tuberculosis in household contacts in Myanmar.
    Int J Tuberc Lung Dis. 2017;21:181-187.
    PubMed     Text format     Abstract available


  34. GUGLIELMETTI L, Hewison C, Avaliani Z, Hughes J, et al
    Examples of bedaquiline introduction for the management of multidrug-resistant tuberculosis in five countries.
    Int J Tuberc Lung Dis. 2017;21:167-174.
    PubMed     Text format     Abstract available


  35. CHIPINDURO M, Mateveke K, Makamure B, Ferrand RA, et al
    Stool Xpert(R) MTB/RIF test for the diagnosis of childhood pulmonary tuberculosis at primary clinics in Zimbabwe.
    Int J Tuberc Lung Dis. 2017;21:161-166.
    PubMed     Text format     Abstract available


  36. CHIANG SS, Roche S, Contreras C, Del Castillo H, et al
    Barriers to the treatment of childhood tuberculous infection and tuberculosis disease: a qualitative study.
    Int J Tuberc Lung Dis. 2017;21:154-160.
    PubMed     Text format     Abstract available


  37. LOPEZ C, Bertram-Farough A, Heywood D, Dawson L, et al
    Knowing about you: eliciting dimensions of personhood within tuberculosis care.
    Int J Tuberc Lung Dis. 2017;21:149-153.
    PubMed     Text format     Abstract available


  38. PARENT SN, Ehrlich R, Baxter V, Kannemeyer N, et al
    Participatory theatre and tuberculosis: a feasibility study with South African health care workers.
    Int J Tuberc Lung Dis. 2017;21:140-148.
    PubMed     Text format     Abstract available


  39. STAGG HR, Lipman MC, McHugh TD, Jenkins HE, et al
    Isoniazid-resistant tuberculosis: a cause for concern?
    Int J Tuberc Lung Dis. 2017;21:129-139.
    PubMed     Text format     Abstract available


    January 2017
  40. RIEDER HL, Van Deun A
    Rationale for high-dose isoniazid in the treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:123-124.
    PubMed     Text format    


  41. REVES R, Benjamin R
    The cost of the failure to eliminate tuberculosis in the United States.
    Int J Tuberc Lung Dis. 2017;21:120.
    PubMed     Text format    


  42. KUMAR NP, Velayutham B, Nair D, Babu S, et al
    Angiopoietins as biomarkers of disease severity and bacterial burden in pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:93-99.
    PubMed     Text format     Abstract available


  43. DAVIS A, Terlikbayeva A, Aifah A, Hermosilla S, et al
    Risks for tuberculosis in Kazakhstan: implications for prevention.
    Int J Tuberc Lung Dis. 2017;21:86-92.
    PubMed     Text format     Abstract available


  44. SHAWENO D, Shaweno T, Trauer JM, Denholm JT, et al
    Heterogeneity of distribution of tuberculosis in Sheka Zone, Ethiopia: drivers and temporal trends.
    Int J Tuberc Lung Dis. 2017;21:79-85.
    PubMed     Text format     Abstract available


  45. KOURA KG, Trebucq A, Schwoebel V
    Do active case-finding projects increase the number of tuberculosis cases notified at national level?
    Int J Tuberc Lung Dis. 2017;21:73-78.
    PubMed     Text format     Abstract available


  46. RUDOLF F, Wagner AJ, Back FM, Gomes VF, et al
    Tuberculosis case finding and mortality prediction: added value of the clinical TBscore and biomarker suPAR.
    Int J Tuberc Lung Dis. 2017;21:67-72.
    PubMed     Text format     Abstract available


  47. RAGONNET R, Trauer JM, McBryde ES, Houben RM, et al
    Is IPT more effective in high-burden settings? Modelling the effect of tuberculosis incidence on IPT impact.
    Int J Tuberc Lung Dis. 2017;21:60-66.
    PubMed     Text format     Abstract available


  48. CHABALA C, Chongwe G, Jumbe-Marsden E, Somwe SW, et al
    Missed opportunities for screening child contacts of smear-positive tuberculosis in Zambia, a high-prevalence setting.
    Int J Tuberc Lung Dis. 2017;21:53-59.
    PubMed     Text format     Abstract available


  49. EGERE U, Togun T, Sillah A, Mendy F, et al
    Identifying children with tuberculosis among household contacts in The Gambia.
    Int J Tuberc Lung Dis. 2017;21:46-52.
    PubMed     Text format     Abstract available


  50. ZELDOW B, Kim S, McSherry G, Cotton MF, et al
    Use of antiretrovirals in HIV-infected children in a tuberculosis prevention trial: IMPAACT P1041.
    Int J Tuberc Lung Dis. 2017;21:38-45.
    PubMed     Text format     Abstract available


  51. JERENE D, Abebe W, Taye K, Suarez PG, et al
    Tuberculosis along the continuum of HIV care in a cohort of adolescents living with HIV in Ethiopia.
    Int J Tuberc Lung Dis. 2017;21:32-37.
    PubMed     Text format     Abstract available


  52. TUPASI T, Garfin AM, Mangan JM, Orillaza-Chi R, et al
    Multidrug-resistant tuberculosis patients' views of interventions to reduce treatment loss to follow-up.
    Int J Tuberc Lung Dis. 2017;21:23-31.
    PubMed     Text format     Abstract available


  53. WELDEGEBREAL S, Mebrahtu T
    Anti-tuberculosis drug resistance in Ethiopia: systematic review.
    Int J Tuberc Lung Dis. 2017;21:18-22.
    PubMed     Text format     Abstract available


  54. BANU S, Rahman MT, Ahmed S, Khatun R, et al
    Multidrug-resistant tuberculosis in Bangladesh: results from a sentinel surveillance system.
    Int J Tuberc Lung Dis. 2017;21:12-17.
    PubMed     Text format     Abstract available


  55. NOURZAD S, Jenkins HE, Milstein M, Mitnick CD, et al
    Estimating the global burden of multidrug-resistant tuberculosis among prevalent cases of tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:6-11.
    PubMed     Text format     Abstract available


  56. FURIN J, Diacon AH, Andries K
    Combating drug-resistant tuberculosis: the unexpected benefits of bedaquiline.
    Int J Tuberc Lung Dis. 2017;21:4-5.
    PubMed     Text format    


    December 2016
  57. STURKENBOOM MG, Bolhuis MS, Akkerman OW, de Lange WC, et al
    Therapeutic drug monitoring of first-line anti-tuberculosis drugs comprises more than C2h measurements.
    Int J Tuberc Lung Dis. 2016;20:1695-1696.
    PubMed     Text format    


  58. VELAYUTHAM B, Nair D, Kannan T, Padmapriyadarsini C, et al
    Factors associated with sputum culture conversion in multidrug-resistant pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1671-1676.
    PubMed     Text format     Abstract available


  59. SINGANAYAGAM A, Manalan K, Connell DW, Chalmers JD, et al
    Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1653-1660.
    PubMed     Text format     Abstract available


  60. EL AZBAOUI S, Sabri A, Ouraini S, Hassani A, et al
    Utility of the QuantiFERON-TB Gold In-Tube assay for the diagnosis of tuberculosis in Moroccan children.
    Int J Tuberc Lung Dis. 2016;20:1639-1646.
    PubMed     Text format     Abstract available


  61. CONNERS E, Garfein RS, Rodwell TC, Udwadia ZF, et al
    Mobility patterns of persons at risk for drug-resistant tuberculosis in Mumbai, India.
    Int J Tuberc Lung Dis. 2016;20:1633-1638.
    PubMed     Text format     Abstract available


  62. ZELNICK JR, O'Donnell MR, Ahuja SD, Chua A, et al
    Health care provider perspectives on tuberculosis care for foreign-born populations in New York City.
    Int J Tuberc Lung Dis. 2016;20:1625-1632.
    PubMed     Text format     Abstract available


  63. BRIGHT-THOMAS RJ, Gondker AR, Morris J, Ormerod LP, et al
    Drug-related hepatitis in patients treated with standard anti-tuberculosis chemotherapy over a 30-year period.
    Int J Tuberc Lung Dis. 2016;20:1621-1624.
    PubMed     Text format     Abstract available


  64. RENDELL NL, Batjargal N, Jadambaa N, Dobler CC, et al
    Risk of tuberculosis during pregnancy in Mongolia, a high incidence setting with low HIV prevalence.
    Int J Tuberc Lung Dis. 2016;20:1615-1620.
    PubMed     Text format     Abstract available


  65. MBATCHOU NGAHANE BH, Dahirou F, Tchieche C, Wandji A, et al
    Clinical characteristics and outcomes of tuberculosis in Douala, Cameroon: a 7-year retrospective cohort study.
    Int J Tuberc Lung Dis. 2016;20:1609-1614.
    PubMed     Text format     Abstract available


  66. SIROKA A, Law I, Macinko J, Floyd K, et al
    The effect of household poverty on tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1603-1608.
    PubMed     Text format     Abstract available


  67. MARGALIT I, Block C, Mor Z
    Seasonality of tuberculosis in Israel, 20012011.
    Int J Tuberc Lung Dis. 2016;20:1588-1593.
    PubMed     Text format     Abstract available


  68. JENSEN SG, Lillebaek T, Wilcke T, Pedersen MK, et al
    Impact of contact investigation and tuberculosis screening among high-risk groups in Denmark.
    Int J Tuberc Lung Dis. 2016;20:1580-1587.
    PubMed     Text format     Abstract available


  69. CASTRO KG
    Detection and treatment of persons with latent tuberculosis infection: first eliminate the policy-to-practice gap.
    Int J Tuberc Lung Dis. 2016;20:1565.
    PubMed     Text format    


  70. TALAVERA-PAULIN M, Garcia-Morales L, Ruiz-Sanchez BP, Caamal-Ley AD, et al
    Active tuberculosis patients have high levels of IgA anti-alpha-crystallin and isocitrate lyase proteins.
    Int J Tuberc Lung Dis. 2016;20:1681-1688.
    PubMed     Text format     Abstract available


  71. EL AZBAOUI S, Sabri A, Ouraini S, Hassani A, et al
    Utility of the QuantiFERON(R)-TB Gold In-Tube assay for the diagnosis of tuberculosis in Moroccan children.
    Int J Tuberc Lung Dis. 2016;20:1639-1646.
    PubMed     Text format     Abstract available


  72. MBATCHOU NGAHANE BH, Dahirou F, Tchieche C, Wandji A, et al
    Clinical characteristics and outcomes of tuberculosis in Douala, Cameroon: a 7-year retrospective cohort study.
    Int J Tuberc Lung Dis. 2016;20:1609-1614.
    PubMed     Text format     Abstract available


  73. MARGALIT I, Block C, Mor Z
    Seasonality of tuberculosis in Israel, 2001-2011.
    Int J Tuberc Lung Dis. 2016;20:1588-1593.
    PubMed     Text format     Abstract available


  74. BRUGUERAS S, Orcau A, Millet JP, Espinosa L, et al
    Tuberculosis clinical units improve contact tracing.
    Int J Tuberc Lung Dis. 2016;20:1572-1579.
    PubMed     Text format     Abstract available


  75. O'DONNELL MR, Padayatchi N, Metcalfe JZ
    Elucidating the role of clofazimine for the treatment of tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:52-57.
    PubMed     Text format     Abstract available


  76. NUERMBERGER E
    Evolving strategies for dose optimization of linezolid for treatment of tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:48-51.
    PubMed     Text format     Abstract available


  77. STERLING TR
    Fluoroquinolones for the treatment and prevention of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:42-47.
    PubMed     Text format     Abstract available


  78. MURRAY S, Mendel C, Spigelman M
    TB Alliance regimen development for multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:38-41.
    PubMed     Text format     Abstract available


  79. GUPTA R, Wells CD, Hittel N, Hafkin J, et al
    Delamanid in the treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:33-37.
    PubMed     Text format     Abstract available


  80. MILSTEIN M, Brzezinski A, Varaine F, Mitnick CD, et al
    (Re)moving the needle: prospects for all-oral treatment for multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:18-23.
    PubMed     Text format     Abstract available


    November 2016
  81. DHOLAKIA Y, Mistry N
    Active tuberculosis case finding in a migrant slum community, Mumbai, India.
    Int J Tuberc Lung Dis. 2016;20:1562.
    PubMed     Text format    


  82. LEVIN A, Sklyuev S, Felker I, Tceymach E, et al
    Endobronchial valve treatment of destructive multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1539-1545.
    PubMed     Text format     Abstract available


  83. PINA RZ, Caleffi-Ferracioli KR, Campanerut-Sa PA, Ghiraldi-Lopez LD, et al
    Pyrazinamide susceptibility testing in Mycobacterium tuberculosis using the fast resazurin microtiter assay plate.
    Int J Tuberc Lung Dis. 2016;20:1535-1538.
    PubMed     Text format     Abstract available


  84. ALIPANAH N, Cattamanchi A, Menzies R, Hopewell PC, et al
    Treatment of non-cavitary pulmonary tuberculosis with shortened fluoroquinolone-based regimens: a meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:1522-1528.
    PubMed     Text format     Abstract available


  85. KIM CH, Lim JK, Lee DH, Yoo SS, et al
    Outcomes of standard and tailored anti-tuberculosis regimens in patients with tuberculous pleural effusion.
    Int J Tuberc Lung Dis. 2016;20:1516-1521.
    PubMed     Text format     Abstract available


  86. IGLECIAS LM, Puga MA, Pompilio MA, Teles SA, et al
    Epidemiological study of hepatitis B virus among prisoners with active tuberculosis in Central Brazil.
    Int J Tuberc Lung Dis. 2016;20:1509-1515.
    PubMed     Text format     Abstract available


  87. IZUMI K, Kawatsu L, Ohkado A, Uchimura K, et al
    Evaluating the impact of health resource reconstruction on improving spatial accessibility of tuberculosis care.
    Int J Tuberc Lung Dis. 2016;20:1501-1508.
    PubMed     Text format     Abstract available


  88. LOPEZ AL, Aldaba JG, Ama CG, Sylim PG, et al
    Surveillance for tuberculosis in a rural community in The Philippines.
    Int J Tuberc Lung Dis. 2016;20:1495-1500.
    PubMed     Text format     Abstract available


  89. NOESKE J, Nana Yakam A, Abena Foe JL
    Epidemiology of tuberculosis in Cameroon as mirrored in notification data, 2006-2014.
    Int J Tuberc Lung Dis. 2016;20:1489-1494.
    PubMed     Text format     Abstract available


  90. DAFTARY A, Padayatchi N
    Provider perspectives on drug-resistant tuberculosis and human immunodeficiency virus care in South Africa: a qualitative case study.
    Int J Tuberc Lung Dis. 2016;20:1483-1488.
    PubMed     Text format     Abstract available


  91. MIBEI DJ, Kiarie JW, Wairia A, Kamene M, et al
    Treatment outcomes of drug-resistant tuberculosis patients in Kenya.
    Int J Tuberc Lung Dis. 2016;20:1477-1482.
    PubMed     Text format     Abstract available


  92. GARCIA-PRATS AJ, du Plessis L, Draper HR, Burger A, et al
    Outcome of culture-confirmed isoniazid-resistant rifampicin-susceptible tuberculosis in children.
    Int J Tuberc Lung Dis. 2016;20:1469-1476.
    PubMed     Text format     Abstract available


  93. CHAYA S, Dangor Z, Solomon F, Nzenze SA, et al
    Incidence of tuberculosis meningitis in a high HIV prevalence setting: time-series analysis from 2006 to 2011.
    Int J Tuberc Lung Dis. 2016;20:1457-1462.
    PubMed     Text format     Abstract available


  94. TURKOVA A, Chappell E, Chalermpantmetagul S, Negra MD, et al
    Tuberculosis in HIV-infected children in Europe, Thailand and Brazil: paediatric TB-HIV EuroCoord study.
    Int J Tuberc Lung Dis. 2016;20:1448-1456.
    PubMed     Text format     Abstract available


  95. JAGANATH D, Lamichhane G, Shah M
    Carbapenems against Mycobacterium tuberculosis: a review of the evidence.
    Int J Tuberc Lung Dis. 2016;20:1436-1447.
    PubMed     Text format     Abstract available


  96. UPLEKAR M
    Public-private mix for tuberculosis care and prevention. What progress? What prospects?
    Int J Tuberc Lung Dis. 2016;20:1424-1429.
    PubMed     Text format     Abstract available


    October 2016
  97. NUNN A, Tweed C
    Treatment regimens for rifampicin-resistant tuberculosis: highlighting a research gap.
    Int J Tuberc Lung Dis. 2016;20:1418-1419.
    PubMed     Text format    


  98. KARAKAS A, Turhan V, Esquinas AM
    Reasons for high mortality rates in patients with pulmonary tuberculosis needing mechanical ventilation.
    Int J Tuberc Lung Dis. 2016;20:1416-1417.
    PubMed     Text format    


  99. FRIEDEN TR
    Positive bacteriological results among contacts of patients with active tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1416.
    PubMed     Text format    


  100. NAIDOO P, Dunbar R, du Toit E, van Niekerk M, et al
    Comparing laboratory costs of smear/culture and Xpert(R) MTB/RIF-based tuberculosis diagnostic algorithms.
    Int J Tuberc Lung Dis. 2016;20:1377-1385.
    PubMed     Text format     Abstract available


  101. ZHAO Q, Xiao X, Lu W, Qiu LX, et al
    Screening diabetes in tuberculosis patients in eastern rural China: a community-based cross-sectional study.
    Int J Tuberc Lung Dis. 2016;20:1370-1376.
    PubMed     Text format     Abstract available


  102. WATTANAPOKAYAKIT S, Mushiroda T, Yanai H, Wichukchinda N, et al
    NAT2 slow acetylator associated with anti-tuberculosis drug-induced liver injury in Thai patients.
    Int J Tuberc Lung Dis. 2016;20:1364-1369.
    PubMed     Text format     Abstract available


  103. THIEL BA, Bark CM, Nakibali JG, van der Kuyp F, et al
    Reader variability and validation of the Timika X-ray score during treatment of pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1358-1363.
    PubMed     Text format     Abstract available


  104. PARCHURE R, Kulkarni V, Gangakhedkar R, Swaminathan S, et al
    Treatment outcomes of daily anti-tuberculosis treatment in HIV-infected patients seeking care at a private clinic in India.
    Int J Tuberc Lung Dis. 2016;20:1348-1353.
    PubMed     Text format     Abstract available


  105. TOLLEFSON D, Ngari F, Mwakala M, Gethi D, et al
    Under-reporting of sputum smear-positive tuberculosis cases in Kenya.
    Int J Tuberc Lung Dis. 2016;20:1334-1341.
    PubMed     Text format     Abstract available


  106. SENKORO M, Kumar AM, Chinnakali P, Mfinanga SG, et al
    Population impact of factors associated with prevalent pulmonary tuberculosis in Tanzania.
    Int J Tuberc Lung Dis. 2016;20:1326-1333.
    PubMed     Text format     Abstract available


  107. ENANE LA, Lowenthal ED, Arscott-Mills T, Matlhare M, et al
    Loss to follow-up among adolescents with tuberculosis in Gaborone, Botswana.
    Int J Tuberc Lung Dis. 2016;20:1320-1325.
    PubMed     Text format     Abstract available


  108. STILLSON CH, Okatch H, Frasso R, Mazhani L, et al
    'That's when I struggle' ... Exploring challenges faced by care givers of children with tuberculosis in Botswana.
    Int J Tuberc Lung Dis. 2016;20:1314-1319.
    PubMed     Text format     Abstract available


  109. SULIS G, Gnanou S, Roggi A, Konseimbo A, et al
    Active tuberculosis case finding among pregnant women: a pilot project in Burkina Faso.
    Int J Tuberc Lung Dis. 2016;20:1306-1308.
    PubMed     Text format     Abstract available


  110. MUNANG ML, Browne C, Evans JT, Smith EG, et al
    Programmatic utility of tuberculosis cluster investigation using a social network approach in Birmingham, United Kingdom.
    Int J Tuberc Lung Dis. 2016;20:1300-1305.
    PubMed     Text format     Abstract available


  111. TEBRUEGGE M, Buonsenso D, Brinkmann F, Noguera-Julian A, et al
    European shortage of purified protein derivative and its impact on tuberculosis screening practices.
    Int J Tuberc Lung Dis. 2016;20:1293-1299.
    PubMed     Text format     Abstract available


  112. TREBUCQ A, Schwoebel V
    Numbers of tuberculosis cases: dreams and reality.
    Int J Tuberc Lung Dis. 2016;20:1288-1292.
    PubMed     Text format     Abstract available


  113. LONG R, Lau A
    How R G Ferguson's groundbreaking studies influenced our understanding of tuberculosis reinfection. Where to next?
    Int J Tuberc Lung Dis. 2016;20:1285-1287.
    PubMed     Text format    


  114. LONNROTH K, Shah NS, Lange C
    State-of-the-art series on tuberculosis and migration.
    Int J Tuberc Lung Dis. 2016;20:1280-1281.
    PubMed     Text format    


    September 2016
  115. EILERTSON B, Maruri F, Blackman A, Herrera M, et al
    Reversion of phenotypic fluoroquinolone resistance in Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1276-7.
    PubMed     Text format    


  116. OTTO-KNAPP R, Vesenbeckh S, Schonfeld N, Bettermann G, et al
    Isoniazid minimal inhibitory concentrations of tuberculosis strains with katG mutation.
    Int J Tuberc Lung Dis. 2016;20:1275-6.
    PubMed     Text format    


  117. HEMANTH KUMAR AK, Kannan T, Chandrasekaran V, Sudha V, et al
    Pharmacokinetics of thrice-weekly rifampicin, isoniazid and pyrazinamide in adult tuberculosis patients in India.
    Int J Tuberc Lung Dis. 2016;20:1236-41.
    PubMed     Text format     Abstract available


  118. PANDE T, Cohen C, Pai M, Ahmad Khan F, et al
    Computer-aided detection of pulmonary tuberculosis on digital chest radiographs: a systematic review.
    Int J Tuberc Lung Dis. 2016;20:1226-30.
    PubMed     Text format     Abstract available


  119. NUNES C, Taylor BM
    Modelling the time to detection of urban tuberculosis in two big cities in Portugal: a spatial survival analysis.
    Int J Tuberc Lung Dis. 2016;20:1219-25.
    PubMed     Text format     Abstract available


  120. MANGAN JM, Tupasi TE, Garfin AM, Lofranco V, et al
    Multidrug-resistant tuberculosis patients lost to follow-up: self-reported readiness to restart treatment.
    Int J Tuberc Lung Dis. 2016;20:1205-11.
    PubMed     Text format     Abstract available


  121. KWEDI NOLNA S, Kammogne ID, Ndzinga R, Afanda B, et al
    Community knowledge, attitudes and practices in relation to tuberculosis in Cameroon.
    Int J Tuberc Lung Dis. 2016;20:1199-204.
    PubMed     Text format     Abstract available


  122. DEMEMEW ZG, Habte D, Melese M, Hamusse SD, et al
    Trends in tuberculosis case notification and treatment outcomes after interventions in 10 zones of Ethiopia.
    Int J Tuberc Lung Dis. 2016;20:1192-8.
    PubMed     Text format     Abstract available


  123. KAPLAN R, Caldwell J, Hermans S, Adriaanse S, et al
    An integrated community TB-HIV adherence model provides an alternative to DOT for tuberculosis patients in Cape Town.
    Int J Tuberc Lung Dis. 2016;20:1185-91.
    PubMed     Text format     Abstract available


  124. JENKS JD, Kumarasamy N, Ezhilarasi C, Poongulali S, et al
    Improved tuberculosis outcomes with daily vs. intermittent rifabutin in HIV-TB coinfected patients in India.
    Int J Tuberc Lung Dis. 2016;20:1181-4.
    PubMed     Text format     Abstract available


  125. YHI JY, Park DW, Min JH, Park YK, et al
    Measurement of levels of fractional exhaled nitric oxide in patients with pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1174-80.
    PubMed     Text format     Abstract available


  126. BHATRAJU P, Patrawalla P, Trieu L, Ahuja SD, et al
    Errors in isolation of patients with infectious tuberculosis at a public teaching hospital in New York.
    Int J Tuberc Lung Dis. 2016;20:1168-73.
    PubMed     Text format     Abstract available


  127. RAO SA, Kadhiravan T, Swaminathan RP, Mahadevan S, et al
    Occupational exposure and tuberculosis among medical residents in a high-burden setting: an open-cohort study.
    Int J Tuberc Lung Dis. 2016;20:1162-7.
    PubMed     Text format     Abstract available


  128. TAYLOR JG, Yates TA, Mthethwa M, Tanser F, et al
    Measuring ventilation and modelling M. tuberculosis transmission in indoor congregate settings, rural KwaZulu-Natal.
    Int J Tuberc Lung Dis. 2016;20:1155-61.
    PubMed     Text format     Abstract available


  129. SUTHAR AB, Zachariah R, Harries AD
    Ending tuberculosis by 2030: can we do it?
    Int J Tuberc Lung Dis. 2016;20:1148-54.
    PubMed     Text format     Abstract available


  130. CHIANG CY, Van Deun A, Rieder HL
    Gatifloxacin for short, effective treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1143-7.
    PubMed     Text format     Abstract available


  131. TWEED C, Nunn A
    Occupational exposure to tuberculosis in endemic areas: room for improvement.
    Int J Tuberc Lung Dis. 2016;20:1139.
    PubMed     Text format    


  132. SCARDIGLI A, Caminero JA
    Simple and practical measures to reduce tuberculosis transmission in public buildings.
    Int J Tuberc Lung Dis. 2016;20:1137-8.
    PubMed     Text format    


    August 2016
  133. DAUM LT, Fourie PB, Peters RP, Rodriguez JD, et al
    Xpert((R)) MTB/RIF detection of Mycobacterium tuberculosis from sputum collected in molecular transport medium.
    Int J Tuberc Lung Dis. 2016;20:1118-24.
    PubMed     Text format     Abstract available


  134. ATWEBEMBEIRE J, Orikiriza P, Bonnet M, Atwine D, et al
    Xpert((R)) MTB/RIF for detection of Mycobacterium tuberculosis from frozen string and induced sputum sediments.
    Int J Tuberc Lung Dis. 2016;20:1113-7.
    PubMed     Text format     Abstract available


  135. BOLLELA VR, Namburete EI, Feliciano CS, Macheque D, et al
    Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1099-104.
    PubMed     Text format     Abstract available


  136. MONTGOMERY CM
    Adaptive trials for tuberculosis: early reflections on theory and practice.
    Int J Tuberc Lung Dis. 2016;20:1091-8.
    PubMed     Text format     Abstract available


  137. STRINGER B, Lowton K, Tillashaikhov M, Parpieva N, et al
    'They prefer hidden treatment': anti-tuberculosis drug-taking practices and drug regulation in Karakalpakstan.
    Int J Tuberc Lung Dis. 2016;20:1084-90.
    PubMed     Text format     Abstract available


  138. TRIASIH R, Padmawati RS, Duke T, Robertson C, et al
    A mixed-methods evaluation of adherence to preventive treatment among child tuberculosis contacts in Indonesia.
    Int J Tuberc Lung Dis. 2016;20:1078-83.
    PubMed     Text format     Abstract available


  139. MARITZ ER, Montepiedra G, Liu L, Mitchell CD, et al
    Source case identification in HIV-exposed infants and tuberculosis diagnosis in an isoniazid prevention study.
    Int J Tuberc Lung Dis. 2016;20:1060-4.
    PubMed     Text format     Abstract available


  140. ADJOBIMEY M, Masserey E, Adjonou C, Gbenagnon G, et al
    Implementation of isoniazid preventive therapy in children aged under 5 years exposed to tuberculosis in Benin.
    Int J Tuberc Lung Dis. 2016;20:1055-9.
    PubMed     Text format     Abstract available


  141. FLICK RJ, Kim MH, Simon K, Munthali A, et al
    Burden of disease and risk factors for death among children treated for tuberculosis in Malawi.
    Int J Tuberc Lung Dis. 2016;20:1046-54.
    PubMed     Text format     Abstract available


  142. BRENNAN AT, Bonawitz R, Schnippel K, Berhanu R, et al
    Incident tuberculosis in HIV-positive children, adolescents and adults on antiretroviral therapy in South Africa.
    Int J Tuberc Lung Dis. 2016;20:1040-5.
    PubMed     Text format     Abstract available


  143. HENOSTROZA G, Harris JB, Chitambi R, Siyambango M, et al
    High prevalence of tuberculosis in newly enrolled HIV patients in Zambia: need for enhanced screening approach.
    Int J Tuberc Lung Dis. 2016;20:1033-9.
    PubMed     Text format     Abstract available


  144. SOUSA P, Oliveira A, Gomes M, Gaio AR, et al
    Longitudinal clustering of tuberculosis incidence and predictors for the time profiles: the impact of HIV.
    Int J Tuberc Lung Dis. 2016;20:1027-32.
    PubMed     Text format     Abstract available


  145. SUBRAMANI R, Gomathy S, Lakshmi M, Swaminathan S, et al
    Trend in the incidence of smear-positive tuberculosis in a district in South India after DOTS implementation.
    Int J Tuberc Lung Dis. 2016;20:1022-6.
    PubMed     Text format     Abstract available


  146. SENKORO M, Mfinanga S, Egwaga S, Mtandu R, et al
    Prevalence of pulmonary tuberculosis in adult population of Tanzania: a national survey, 2012.
    Int J Tuberc Lung Dis. 2016;20:1014-21.
    PubMed     Text format     Abstract available


  147. SABIITI W, Mtafya B, Kuchaka D, Azam K, et al
    Optimising molecular diagnostic capacity for effective control of tuberculosis in high-burden settings.
    Int J Tuberc Lung Dis. 2016;20:1004-9.
    PubMed     Text format     Abstract available


  148. ANDRE E, Isaacs C, Affolabi D, Alagna R, et al
    Connectivity of diagnostic technologies: improving surveillance and accelerating tuberculosis elimination.
    Int J Tuberc Lung Dis. 2016;20:999-1003.
    PubMed     Text format     Abstract available


  149. HESSELING AC, Rabie H
    Tuberculosis and HIV remain major causes of death in African children.
    Int J Tuberc Lung Dis. 2016;20:996-7.
    PubMed     Text format    


    July 2016
  150. MAJUMDER A, Carroll B, Bhana S, Tefu D, et al
    Screening for active tuberculosis in a diabetes mellitus clinic in Soweto, South Africa.
    Int J Tuberc Lung Dis. 2016;20:992-3.
    PubMed     Text format    


  151. GERONA R, Wen A, Koss C, Bacchetti P, et al
    A multi-analyte panel for non-invasive pharmacokinetic monitoring of second-line anti-tuberculosis drugs.
    Int J Tuberc Lung Dis. 2016;20:991-2.
    PubMed     Text format    


  152. CASTRO JL
    In reply: The language of tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:989-90.
    PubMed     Text format    


  153. DESHMUKH R
    Targeting zero tuberculosis deaths among people living with HIV: a call for action.
    Int J Tuberc Lung Dis. 2016;20:988.
    PubMed     Text format    


  154. LESSEM E, Frick M
    Ensuring availability of the best tuberculosis treatment options in the Philippines.
    Int J Tuberc Lung Dis. 2016;20:988-9.
    PubMed     Text format    


  155. OH KH, Kim HJ, Kim MH
    Non-communicable diseases and risk of tuberculosis in Korea.
    Int J Tuberc Lung Dis. 2016;20:973-7.
    PubMed     Text format     Abstract available


  156. YIN XM, Wu LJ, Zheng L, Mao XR, et al
    Quantification of colony-forming units for M. tuberculosis complex using gyrB-based real-time PCR assay.
    Int J Tuberc Lung Dis. 2016;20:967-72.
    PubMed     Text format     Abstract available


  157. SHIN SS, Chang AH, Ghosh JK, Dube MP, et al
    Isoniazid therapy for Mycobacterium tuberculosis infection in HIV clinics, Los Angeles, California.
    Int J Tuberc Lung Dis. 2016;20:961-6.
    PubMed     Text format     Abstract available


  158. MAZE MJ, Paynter J, Chiu W, Hu R, et al
    Therapeutic drug monitoring of isoniazid and rifampicin during anti-tuberculosis treatment in Auckland, New Zealand.
    Int J Tuberc Lung Dis. 2016;20:955-60.
    PubMed     Text format     Abstract available


  159. CHOI H, Chung H, Muntaner C, Lee M, et al
    The impact of social conditions on patient adherence to pulmonary tuberculosis treatment.
    Int J Tuberc Lung Dis. 2016;20:948-54.
    PubMed     Text format     Abstract available


  160. CASTRO KG, Marks SM, Chen MP, Hill AN, et al
    Estimating tuberculosis cases and their economic costs averted in the United States over the past two decades.
    Int J Tuberc Lung Dis. 2016;20:926-33.
    PubMed     Text format     Abstract available


  161. IBARZ-PAVON AB, Papaventsis D, Kalkouni R, Metaxas G, et al
    Pilot study of the completeness of notification of adult tuberculosis in Athens, Greece.
    Int J Tuberc Lung Dis. 2016;20:920-5.
    PubMed     Text format     Abstract available


  162. PAVLINAC PB, Lokken EM, Walson JL, Richardson BA, et al
    Mycobacterium tuberculosis bacteremia in adults and children: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:895-902.
    PubMed     Text format     Abstract available


  163. BARES R, Khalid N, Daniel H, Dittmann H, et al
    Hypothyroidism during second-line treatment of multidrug-resistant tuberculosis: a prospective study.
    Int J Tuberc Lung Dis. 2016;20:876-81.
    PubMed     Text format     Abstract available


  164. STAGG HR, Hatherell HA, Lipman MC, Harris RJ, et al
    Treatment regimens for rifampicin-resistant tuberculosis: highlighting a research gap.
    Int J Tuberc Lung Dis. 2016;20:866-9.
    PubMed     Text format     Abstract available


  165. DEAN AS, Zignol M, Lumb R, Lalor M, et al
    Sputum smear microscopy result: a predictor for drug-resistant tuberculosis?
    Int J Tuberc Lung Dis. 2016;20:864-5.
    PubMed     Text format     Abstract available


  166. KOETHE JR, von Reyn CF
    Protein-calorie malnutrition, macronutrient supplements, and tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:857-63.
    PubMed     Text format     Abstract available


    June 2016
  167. BALCELLS ME, Huilcaman M, Pena C, Castillo C, et al
    M. tuberculosis DNA detection in nasopharyngeal mucosa can precede tuberculosis development in contacts.
    Int J Tuberc Lung Dis. 2016;20:848-52.
    PubMed     Text format     Abstract available


  168. MAVE V, Chandanwale A, Kinikar A, Khadse S, et al
    Isoniazid hair concentrations in children with tuberculosis: a proof of concept study.
    Int J Tuberc Lung Dis. 2016;20:844-7.
    PubMed     Text format     Abstract available


  169. SINGH M, Sethi GR, Mantan M, Khanna A, et al
    Xpert((R)) MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children.
    Int J Tuberc Lung Dis. 2016;20:839-43.
    PubMed     Text format     Abstract available


  170. JINDANI A, Borgulya G, de Patino IW, Gonzales T, et al
    A randomised Phase II trial to evaluate the toxicity of high-dose rifampicin to treat pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:832-8.
    PubMed     Text format     Abstract available


  171. HOLLAND DP, Hamilton CD, Stout JE
    Tackling the unknowns of short-course rifapentine-based treatment for active tuberculosis: a decision analysis.
    Int J Tuberc Lung Dis. 2016;20:827-31.
    PubMed     Text format     Abstract available


  172. MOTA L, Al-Efraij K, Campbell JR, Cook VJ, et al
    Therapeutic drug monitoring in anti-tuberculosis treatment: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:819-26.
    PubMed     Text format     Abstract available


  173. CHEN R, Wang J, Tang SW, Zhang Y, et al
    CYP7A1, BAAT and UGT1A1 polymorphisms and susceptibility to anti-tuberculosis drug-induced hepatotoxicity.
    Int J Tuberc Lung Dis. 2016;20:812-8.
    PubMed     Text format     Abstract available


  174. DHATWALIA SK, Yadav R, Behera D, Rudramurthy SM, et al
    Distribution and association of Mycobacterium tuberculosis CAS lineage with multidrug resistance in North India.
    Int J Tuberc Lung Dis. 2016;20:806-11.
    PubMed     Text format     Abstract available


  175. LEE SS, Lee CM, Kim TH, Kim JJ, et al
    Frequency and risk factors of drug-induced liver injury during treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:800-5.
    PubMed     Text format     Abstract available


  176. SANDER MS, Vuchas CY, Numfor HN, Nsimen AN, et al
    Sputum bacterial load predicts multidrug-resistant tuberculosis in retreatment patients: a case-control study.
    Int J Tuberc Lung Dis. 2016;20:793-9.
    PubMed     Text format     Abstract available


  177. JENSENIUS M, Winje BA, Blomberg B, Mengshoel AT, et al
    Multidrug-resistant tuberculosis in Norway: a nationwide study, 1995-2014.
    Int J Tuberc Lung Dis. 2016;20:786-92.
    PubMed     Text format     Abstract available


  178. MACPHERSON P, Squire SB, Cleary P, Davies S, et al
    Equitable tuberculosis care in the North West of England: analysis of tuberculosis cohort review data.
    Int J Tuberc Lung Dis. 2016;20:778-85.
    PubMed     Text format     Abstract available


  179. CARAFFA E, Schepisi MS, Gualano G, Parracino MP, et al
    The diabetes-tuberculosis co-epidemic: the role of international migration.
    Int J Tuberc Lung Dis. 2016;20:771-7.
    PubMed     Text format     Abstract available


  180. CAMPBELL JR, Krot J, Marra F
    Latent tuberculosis diagnostic tests to predict longitudinal tuberculosis during dialysis: a meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:764-70.
    PubMed     Text format     Abstract available


  181. EVERATT R, Kuzmickiene I, Davidaviciene E, Cicenas S, et al
    Incidence of lung cancer among patients with tuberculosis: a nationwide cohort study in Lithuania.
    Int J Tuberc Lung Dis. 2016;20:757-63.
    PubMed     Text format     Abstract available


  182. LEUNG CC
    Does tuberculosis increase the risk of lung cancer?
    Int J Tuberc Lung Dis. 2016;20:712.
    PubMed     Text format    


    May 2016
  183. BRANAGAN P, Moran B, Fitzgibbon M, Reid V, et al
    Inoculation site leprosy in a tattoo as a paradoxical reaction following tuberculosis treatment.
    Int J Tuberc Lung Dis. 2016;20:706-8.
    PubMed     Text format     Abstract available


  184. ARYANPUR M, Masjedi MR, Hosseini M, Mortaz E, et al
    Cigarette smoking in patients newly diagnosed with pulmonary tuberculosis in Iran.
    Int J Tuberc Lung Dis. 2016;20:679-84.
    PubMed     Text format     Abstract available


  185. YELLAPPA V, Battaglioli T, Gurum SK, Narayanan D, et al
    Private practitioners' contributions to the Revised National Tuberculosis Control Programme in a South Indian district.
    Int J Tuberc Lung Dis. 2016;20:659-65.
    PubMed     Text format     Abstract available


  186. GLOBAN M, Lavender C, Leslie D, Brown L, et al
    Molecular epidemiology of tuberculosis in Victoria, Australia, reveals low level of transmission.
    Int J Tuberc Lung Dis. 2016;20:652-8.
    PubMed     Text format     Abstract available


  187. GURBANOVA E, Mehdiyev R, Blondal K, Altraja A, et al
    Predictors of cure in rifampicin-resistant tuberculosis in prison settings with low loss to follow-up.
    Int J Tuberc Lung Dis. 2016;20:645-51.
    PubMed     Text format     Abstract available


  188. SEIFERT M, Ajbani K, Georghiou SB, Catanzaro D, et al
    A performance evaluation of MTBDRplus version 2 for the diagnosis of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:631-7.
    PubMed     Text format     Abstract available


  189. PINTO M, Steffen RE, Cobelens F, van den Hof S, et al
    Cost-effectiveness of the Xpert((R)) MTB/RIF assay for tuberculosis diagnosis in Brazil.
    Int J Tuberc Lung Dis. 2016;20:611-8.
    PubMed     Text format     Abstract available


  190. QUISPE R, Valle GA, Huapaya JA, Novoa I, et al
    Manual MGIT system for the detection of Mycobacterium tuberculosis: insights from a high TB burden setting.
    Int J Tuberc Lung Dis. 2016;20:605-10.
    PubMed     Text format     Abstract available


  191. JOHNSON MG, Stout JE, Benator DA, Whitworth WC, et al
    Medium matters: modeling the impact of solid medium performance on tuberculosis trial sample size requirements.
    Int J Tuberc Lung Dis. 2016;20:600-4.
    PubMed     Text format     Abstract available


  192. NAKAGGWA P, Odeke R, Kirenga BJ, Bloss E, et al
    Incomplete sputum smear microscopy monitoring among smear-positive tuberculosis patients in Uganda.
    Int J Tuberc Lung Dis. 2016;20:594-9.
    PubMed     Text format     Abstract available


  193. CHUCK C, Robinson E, Macaraig M, Alexander M, et al
    Enhancing management of tuberculosis treatment with video directly observed therapy in New York City.
    Int J Tuberc Lung Dis. 2016;20:588-93.
    PubMed     Text format     Abstract available


  194. NAGAVCI BL, de Gelder R, Martikainen P, Deboosere P, et al
    Inequalities in tuberculosis mortality: long-term trends in 11 European countries.
    Int J Tuberc Lung Dis. 2016;20:574-81.
    PubMed     Text format     Abstract available


  195. CHAULK CP, Belknap R
    A public heath 'selfie' for treating tuberculosis?
    Int J Tuberc Lung Dis. 2016;20:571.
    PubMed     Text format    


  196. VAN RIE A, Taylor R
    Can we translate findings on inequality in tuberculosis mortality into policy?
    Int J Tuberc Lung Dis. 2016;20:569-70.
    PubMed     Text format    


  197. NICOLINI A, Perazzo A, Gatto P, Piroddi IM, et al
    A rare adverse reaction to ethambutol: drug-induced haemolytic anaemia.
    Int J Tuberc Lung Dis. 2016;20:704-5.
    PubMed     Text format     Abstract available


  198. MUKHERJEE A, Velpandian T, Singla M, Kanhiya K, et al
    Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children.
    Int J Tuberc Lung Dis. 2016;20:666-72.
    PubMed     Text format     Abstract available


  199. RUAN YZ, Li RZ, Wang XX, Wang LX, et al
    The affordability for patients of a new universal MDR-TB coverage model in China.
    Int J Tuberc Lung Dis. 2016;20:638-44.
    PubMed     Text format     Abstract available


  200. MODI M, Sharma K, Sharma M, Sharma A, et al
    Multitargeted loop-mediated isothermal amplification for rapid diagnosis of tuberculous meningitis.
    Int J Tuberc Lung Dis. 2016;20:625-30.
    PubMed     Text format     Abstract available


  201. MOK Y, Tan TY, Tay TR, Wong HS, et al
    Do we need transbronchial lung biopsy if we have bronchoalveolar lavage Xpert(R) MTB/RIF?
    Int J Tuberc Lung Dis. 2016;20:619-24.
    PubMed     Text format     Abstract available


    April 2016
  202. BRONNER MURRISON L, Ananthakrishnan R, Swaminathan A, Auguesteen S, et al
    How do patients access the private sector in Chennai, India? An evaluation of delays in tuberculosis diagnosis.
    Int J Tuberc Lung Dis. 2016;20:544-51.
    PubMed     Text format     Abstract available


  203. MCDOWELL A, Pai M
    Treatment as diagnosis and diagnosis as treatment: empirical management of presumptive tuberculosis in India.
    Int J Tuberc Lung Dis. 2016;20:536-43.
    PubMed     Text format     Abstract available


  204. CALDERON HERNAIZ R, Ruiz Giardin JM, Cabello Clotet N, Canora Lebrato J, et al
    Tuberculosis and immigration in an area of southwest Madrid.
    Int J Tuberc Lung Dis. 2016;20:530-5.
    PubMed     Text format     Abstract available


  205. KIM S, Kim H, Kim WJ, Lee SJ, et al
    Mortality and predictors in pulmonary tuberculosis with respiratory failure requiring mechanical ventilation.
    Int J Tuberc Lung Dis. 2016;20:524-9.
    PubMed     Text format     Abstract available


  206. DALE K, Tay E, Trevan P, Denholm JT, et al
    Mortality among tuberculosis cases in Victoria, 2002-2013: case fatality and factors associated with death.
    Int J Tuberc Lung Dis. 2016;20:515-23.
    PubMed     Text format     Abstract available


  207. KANAMORI H, Hatakeyama T, Uchiyama B, Weber DJ, et al
    Clinical and molecular epidemiological features of tuberculosis after the 2011 Japan earthquake and tsunami.
    Int J Tuberc Lung Dis. 2016;20:505-14.
    PubMed     Text format     Abstract available


  208. SWAMINATHAN A, du Cros P, Seddon JA, Quinnell S, et al
    Treating children for drug-resistant tuberculosis in Tajikistan with Group 5 medications.
    Int J Tuberc Lung Dis. 2016;20:474-8.
    PubMed     Text format     Abstract available


  209. HUANG ZK, Luo Q, Qing C, Deng YT, et al
    Evaluation of the direct nitrate reductase assay for rapid detection of extensively drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:468-73.
    PubMed     Text format     Abstract available


  210. LI H, Zhou LP, Luo J, Yu JP, et al
    Rapid colorimetric pyrazinamide susceptibility testing of Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:462-7.
    PubMed     Text format     Abstract available


  211. ZHENG LH, Jia HY, Liu XJ, Sun HS, et al
    Modified cytospin slide microscopy method for rapid diagnosis of smear-negative pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:456-61.
    PubMed     Text format     Abstract available


  212. TAHSEEN S, Qadeer E, Khanzada FM, Rizvi AH, et al
    Use of Xpert((R)) MTB/RIF assay in the first national anti-tuberculosis drug resistance survey in Pakistan.
    Int J Tuberc Lung Dis. 2016;20:448-55.
    PubMed     Text format     Abstract available


  213. MARKS SM, Hirsch-Moverman Y, Salcedo K, Graviss EA, et al
    Characteristics and costs of multidrug-resistant tuberculosis in-patient care in the United States, 2005-2007.
    Int J Tuberc Lung Dis. 2016;20:435-41.
    PubMed     Text format     Abstract available


  214. O'DONNELL MR, Daftary A, Frick M, Hirsch-Moverman Y, et al
    Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV.
    Int J Tuberc Lung Dis. 2016;20:430-4.
    PubMed     Text format     Abstract available


  215. SOTGIU G, Migliori GB
    TB-related mortality: a re-emerging problem in high-income countries?
    Int J Tuberc Lung Dis. 2016;20:428.
    PubMed     Text format    


  216. BILLO NE
    Costs for TB and MDR-TB: time to convene a WHO Emergency Committee on TB?
    Int J Tuberc Lung Dis. 2016;20:427.
    PubMed     Text format    


  217. BANDA H, Robinson R, Thomson R, Squire SB, et al
    The 'Practical Approach to Lung Health' in sub-Saharan Africa: a systematic review.
    Int J Tuberc Lung Dis. 2016;20:552-9.
    PubMed     Text format     Abstract available


  218. YU J, Wang ZJ, Chen LH, Li HH, et al
    Diagnostic accuracy of interferon-gamma release assays for tuberculous meningitis: a meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:494-9.
    PubMed     Text format     Abstract available


  219. WANG F, Hou HY, Wu SJ, Zhu Q, et al
    Using the TBAg/PHA ratio in the T-SPOT((R)).TB assay to distinguish TB disease from LTBI in an endemic area.
    Int J Tuberc Lung Dis. 2016;20:487-93.
    PubMed     Text format     Abstract available


  220. SILVA AP, Hill P, Belo MT, Rabelo SG, et al
    Non-completion of latent tuberculous infection treatment among children in Rio de Janeiro State, Brazil.
    Int J Tuberc Lung Dis. 2016;20:479-86.
    PubMed     Text format     Abstract available


  221. KELLY AM, Smith B, Luo Z, Given B, et al
    Discordance between patient and clinician reports of adverse reactions to MDR-TB treatment.
    Int J Tuberc Lung Dis. 2016;20:442-7.
    PubMed     Text format     Abstract available


    March 2016
  222. SHIN SS, Modongo C, Zetola NM
    The impact of mixed infections on the interpretation of molecular epidemiology studies of tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:423-4.
    PubMed     Text format    


  223. SARIN P, Duffy J, Mughal Z, Hedayat E, et al
    Vitamin D and tuberculosis: review and association in three rural provinces of Afghanistan.
    Int J Tuberc Lung Dis. 2016;20:383-8.
    PubMed     Text format     Abstract available


  224. LO HY, Yang SL, Lin HH, Bai KJ, et al
    Does enhanced diabetes management reduce the risk and improve the outcome of tuberculosis?
    Int J Tuberc Lung Dis. 2016;20:376-82.
    PubMed     Text format     Abstract available


  225. PARR JB, Rich ML, Keshavjee S, Franke MF, et al
    Presumptive treatment of multidrug-resistant tuberculosis in household contacts.
    Int J Tuberc Lung Dis. 2016;20:370-5.
    PubMed     Text format     Abstract available


  226. QIN F, Barry PM, Pascopella L
    Factors associated with extended treatment among tuberculosis patients at risk of relapse in California.
    Int J Tuberc Lung Dis. 2016;20:363-9.
    PubMed     Text format     Abstract available


  227. PAULINO J, Martins A, Machado M, Gomes M, et al
    Tuberculosis in native- and foreign-born populations in Portugal.
    Int J Tuberc Lung Dis. 2016;20:357-62.
    PubMed     Text format     Abstract available


  228. SMITH A, Burger R, Claassens M, Ayles H, et al
    Health care workers' gender bias in testing could contribute to missed tuberculosis among women in South Africa.
    Int J Tuberc Lung Dis. 2016;20:350-6.
    PubMed     Text format     Abstract available


  229. KHAN PY, Glynn JR, Fielding KL, Mzembe T, et al
    Risk factors for Mycobacterium tuberculosis infection in 2-4 year olds in a rural HIV-prevalent setting.
    Int J Tuberc Lung Dis. 2016;20:342-9.
    PubMed     Text format     Abstract available


  230. YU X, Ma YF, Jiang GL, Chen ST, et al
    Sensititre(R) MYCOTB MIC plate for drug susceptibility testing of Mycobacterium tuberculosis complex isolates.
    Int J Tuberc Lung Dis. 2016;20:329-34.
    PubMed     Text format     Abstract available


  231. ZHANG T, Lv CF, Wang J, Zheng WB, et al
    Direct tuberculosis drug susceptibility testing: time-saving and cost-effective in detecting MDR-TB.
    Int J Tuberc Lung Dis. 2016;20:323-8.
    PubMed     Text format     Abstract available


  232. HO J, Nguyen PT, Nguyen TA, Tran HK, et al
    The role of macroscopic sputum quality assessments to optimise sputum testing for tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:319-22.
    PubMed     Text format     Abstract available


  233. HALIM KS, Islam MZ, Fatema N, Khan MD, et al
    Validation of smear-positive tuberculosis diagnoses in Bangladesh.
    Int J Tuberc Lung Dis. 2016;20:314-8.
    PubMed     Text format     Abstract available


  234. MAHESHWARI P, Chauhan K, Kadam R, Pujani A, et al
    Market assessment of tuberculosis diagnostics in India in 2013.
    Int J Tuberc Lung Dis. 2016;20:304-13.
    PubMed     Text format     Abstract available


  235. ZHAO YL, Pang Y, Xia H, Du X, et al
    Market assessment of tuberculosis diagnostics in China in 2012.
    Int J Tuberc Lung Dis. 2016;20:295-303.
    PubMed     Text format     Abstract available


  236. FURIN J, Alirol E, Allen E, Fielding K, et al
    Drug-resistant tuberculosis clinical trials: proposed core research definitions in adults.
    Int J Tuberc Lung Dis. 2016;20:290-4.
    PubMed     Text format     Abstract available


  237. KAPUR A
    Tuberculosis prevention and control: we need to pay heed to diabetes care.
    Int J Tuberc Lung Dis. 2016;20:287.
    PubMed     Text format    


  238. ZUMLA A, Davies PD
    Progress towards achieving global tuberculosis control: so near, yet so far.
    Int J Tuberc Lung Dis. 2016;20:285-6.
    PubMed     Text format    


  239. KOSGEI RJ, Sitienei JK, Kipruto H, Kimenye K, et al
    In reply.
    Int J Tuberc Lung Dis. 2016;20:425-6.
    PubMed     Text format    


  240. HORTON KC, Houben RM, White RG, Corbett EL, et al
    Time for men to count, too.
    Int J Tuberc Lung Dis. 2016;20:425.
    PubMed     Text format    


  241. COWAN J, Michel C, Manhica I, Mutaquiha C, et al
    Remote monitoring of Xpert(R) MTB/RIF testing in Mozambique: results of programmatic implementation of GxAlert.
    Int J Tuberc Lung Dis. 2016;20:335-41.
    PubMed     Text format     Abstract available


    February 2016
  242. SHARMA S, Nahar U, Das A, Radotra B, et al
    Acute respiratory distress syndrome in disseminated tuberculosis: an uncommon association.
    Int J Tuberc Lung Dis. 2016;20:271-5.
    PubMed     Text format     Abstract available


  243. FAN WC, Ou SM, Feng JY, Hu YW, et al
    Increased risk of pulmonary tuberculosis in patients with gastroesophageal reflux disease.
    Int J Tuberc Lung Dis. 2016;20:265-70.
    PubMed     Text format     Abstract available


  244. ZWERLING A, Gomez GB, Pennington J, Cobelens F, et al
    A simplified cost-effectiveness model to guide decision-making for shortened anti-tuberculosis treatment regimens.
    Int J Tuberc Lung Dis. 2016;20:257-60.
    PubMed     Text format     Abstract available


  245. CHANDRA TJ, Selvaraj R, Sharma YV
    Same-day sputum smear microscopy for the diagnosis of pulmonary tuberculosis: direct vs. concentrated smear.
    Int J Tuberc Lung Dis. 2016;20:247-51.
    PubMed     Text format     Abstract available


  246. JEENA L, Naidoo K
    Tuberculosis treatment outcomes among peri-urban children receiving doorstep tuberculosis care.
    Int J Tuberc Lung Dis. 2016;20:235-9.
    PubMed     Text format     Abstract available


  247. NGUYEN DT, Bang ND, Hung NQ, Beasley RP, et al
    Yield of chest radiograph in tuberculosis screening for HIV-infected persons at a district-level HIV clinic.
    Int J Tuberc Lung Dis. 2016;20:211-7.
    PubMed     Text format     Abstract available


  248. NLIWASA M, MacPherson P, Mukaka M, Mdolo A, et al
    High mortality and prevalence of HIV and tuberculosis in adults with chronic cough in Malawi: a cohort study.
    Int J Tuberc Lung Dis. 2016;20:202-10.
    PubMed     Text format     Abstract available


  249. HEYSELL SK, Ogarkov OB, Zhdanova S, Zorkaltseva E, et al
    Undertreated HIV and drug-resistant tuberculosis at a referral hospital in Irkutsk, Siberia.
    Int J Tuberc Lung Dis. 2016;20:187-92.
    PubMed     Text format     Abstract available


  250. LEW WJ, Harrington K, Garfin C, Islam T, et al
    Outcomes of Category I and II regimens in mono- and polyresistant tuberculosis cases in the Philippines.
    Int J Tuberc Lung Dis. 2016;20:170-6.
    PubMed     Text format     Abstract available


  251. MAJUMDAR T, Bhattacharya S, Barman D, Bhoumik P, et al
    Detection of multidrug-resistant tuberculosis using MGIT(TM) and MAS-PCR in Tripura, India.
    Int J Tuberc Lung Dis. 2016;20:166-9.
    PubMed     Text format     Abstract available


  252. GEORGHIOU SB, Ajbani K, Rodrigues C, Rodwell TC, et al
    Performance of a pyrosequencing platform in diagnosing drug-resistant extra-pulmonary tuberculosis in India.
    Int J Tuberc Lung Dis. 2016;20:160-5.
    PubMed     Text format     Abstract available


  253. MILLAN-LOU MI, Olle-Goig JE, Tortola MT, Martin C, et al
    Mycobacterial diversity causing multi- and extensively drug-resistant tuberculosis in Djibouti, Horn of Africa.
    Int J Tuberc Lung Dis. 2016;20:150-3.
    PubMed     Text format     Abstract available


  254. BOYLES TH, Kengne AP
    A priori estimation of diagnostic thresholds could improve the reporting of diagnostic studies of tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:147-9.
    PubMed     Text format    


  255. MITNICK C, van den Hof S
    Using existing data to illustrate-and close-the gap in access to new anti-tuberculosis drugs.
    Int J Tuberc Lung Dis. 2016;20:145.
    PubMed     Text format    


  256. TAKIFF H, Alame-Emane AK, Pierre-Audigier C, Gicquel B, et al
    In reply.
    Int J Tuberc Lung Dis. 2016;20:282-3.
    PubMed     Text format    


  257. COBELENS F, Gebhard A, van den Hof S
    No evidence that pyrazinamide resistance is acquired after fluoroquinolone resistance.
    Int J Tuberc Lung Dis. 2016;20:282.
    PubMed     Text format    


  258. YANG HK, Park MJ, Lee JH, Lee CT, et al
    Incidence of toxic optic neuropathy with low-dose ethambutol.
    Int J Tuberc Lung Dis. 2016;20:261-4.
    PubMed     Text format     Abstract available


  259. SIDIQ Z, Hanif M, Chopra KK, Khanna A, et al
    Random blinded rechecking of AFB smears in a pilot project at an intermediate reference laboratory.
    Int J Tuberc Lung Dis. 2016;20:252-6.
    PubMed     Text format     Abstract available


  260. MBONZE NB, Tabala M, Wenzi LK, Bakoko B, et al
    Xpert((R)) MTB/RIF for smear-negative presumptive TB: impact on case notification in DR Congo.
    Int J Tuberc Lung Dis. 2016;20:240-6.
    PubMed     Text format     Abstract available


  261. SABI I, Kabyemera R, Mshana SE, Kidenya BR, et al
    Pulmonary TB bacteriologically confirmed by induced sputum among children at Bugando Medical Centre, Tanzania.
    Int J Tuberc Lung Dis. 2016;20:228-34.
    PubMed     Text format     Abstract available


  262. ELIAS D, Akuffo H, Abate E, Mekonnen Y, et al
    Risk of tuberculous infection in adolescents and adults in a rural community in Ethiopia.
    Int J Tuberc Lung Dis. 2016;20:218-22.
    PubMed     Text format     Abstract available


  263. KERKHOFF AD, Meintjes G, Opie J, Vogt M, et al
    Anaemia in patients with HIV-associated TB: relative contributions of anaemia of chronic disease and iron deficiency.
    Int J Tuberc Lung Dis. 2016;20:193-201.
    PubMed     Text format     Abstract available


  264. BONNET M, Bastard M, du Cros P, Khamraev A, et al
    Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study.
    Int J Tuberc Lung Dis. 2016;20:177-86.
    PubMed     Text format     Abstract available


  265. NIKAM C, Patel R, Sadani M, Ajbani K, et al
    Redefining MTBDRplus test results: what do indeterminate results actually mean?
    Int J Tuberc Lung Dis. 2016;20:154-9.
    PubMed     Text format     Abstract available


  266. GLAZIOU P, Floyd K, Weil D, Raviglione M, et al
    TB deaths rank alongside HIV deaths as top infectious killer.
    Int J Tuberc Lung Dis. 2016;20:143-4.
    PubMed     Text format    


    January 2016
  267. YANG PL, He XJ, Zang QJ, Li HP, et al
    Association of human leukocyte antigen DRB1 polymorphism and tuberculosis: a meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:121-8.
    PubMed     Text format     Abstract available


  268. WATANABE A, Matsumoto T, Igari H, Sawa J, et al
    Risk of developing active tuberculosis in rheumatoid arthritis patients on adalimumab in Japan.
    Int J Tuberc Lung Dis. 2016;20:101-8.
    PubMed     Text format     Abstract available


  269. BURMEN B, Modi S, Cavanaugh JS, Muttai H, et al
    Tuberculosis screening outcomes for newly diagnosed persons living with HIV, Nyanza Province, Kenya, 2009.
    Int J Tuberc Lung Dis. 2016;20:79-84.
    PubMed     Text format     Abstract available


  270. AGUILERA XP, Gonzalez C, Najera-De Ferrari M, Hirmas M, et al
    Tuberculosis in prisoners and their contacts in Chile: estimating incidence and latent infection.
    Int J Tuberc Lung Dis. 2016;20:63-70.
    PubMed     Text format     Abstract available


  271. CHEN KS, Liu T, Lin RR, Peng YP, et al
    Tuberculosis transmission and risk factors in a Chinese antimony mining community.
    Int J Tuberc Lung Dis. 2016;20:57-62.
    PubMed     Text format     Abstract available


  272. KIM L, Moonan PK, Heilig CM, Woodruff RS, et al
    Factors associated with recurrent tuberculosis more than 12 months after treatment completion.
    Int J Tuberc Lung Dis. 2016;20:49-56.
    PubMed     Text format     Abstract available


  273. SHULDINER J, Leventhal A, Chemtob D, Mor Z, et al
    Mortality after anti-tuberculosis treatment completion: results of long-term follow-up.
    Int J Tuberc Lung Dis. 2016;20:43-8.
    PubMed     Text format     Abstract available


  274. DOMINGUEZ J, Boettger EC, Cirillo D, Cobelens F, et al
    Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET/RESIST-TB consensus statement.
    Int J Tuberc Lung Dis. 2016;20:24-42.
    PubMed     Text format     Abstract available


  275. YATES TA, Tanser F, Abubakar I
    Plan Beta for tuberculosis: it's time to think seriously about poorly ventilated congregate settings.
    Int J Tuberc Lung Dis. 2016;20:5-10.
    PubMed     Text format     Abstract available


  276. SOTGIU G, Centis R, Migliori GB
    Tuberculosis management and determinants of recurrence.
    Int J Tuberc Lung Dis. 2016;20:3.
    PubMed     Text format    


  277. VAN DEN HOF S, Borgdorff MW
    Elevated mortality after successful tuberculosis treatment.
    Int J Tuberc Lung Dis. 2016;20:2.
    PubMed     Text format    


  278. KO Y, Lee HK, Lee YS, Kim MY, et al
    Accuracy of Xpert((R)) MTB/RIF assay compared with AdvanSure TB/NTM real-time PCR using bronchoscopy specimens.
    Int J Tuberc Lung Dis. 2016;20:115-20.
    PubMed     Text format     Abstract available


  279. BENERI CA, Aaron L, Kim S, Jean-Philippe P, et al
    Understanding NIH clinical case definitions for pediatric intrathoracic TB by applying them to a clinical trial.
    Int J Tuberc Lung Dis. 2016;20:93-100.
    PubMed     Text format     Abstract available


  280. KAPOOR S, Gupta A, Shah M
    Cost-effectiveness of isoniazid preventive therapy for HIV-infected pregnant women in India.
    Int J Tuberc Lung Dis. 2016;20:85-92.
    PubMed     Text format     Abstract available


  281. HENSEL RL, Kempker RR, Tapia J, Oladele A, et al
    Increased risk of latent tuberculous infection among persons with pre-diabetes and diabetes mellitus.
    Int J Tuberc Lung Dis. 2016;20:71-8.
    PubMed     Text format     Abstract available


    December 2015
  282. MURRAY S, McKenna L, Pelfrene E, Botgros R, et al
    Accelerating clinical drug development for children with tuberculosis.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:69-74.
    PubMed     Text format     Abstract available


  283. TANEJA R, Garcia-Prats AJ, Furin J, Maheshwari HK, et al
    Paediatric formulations of second-line anti-tuberculosis medications: challenges and considerations.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:61-8.
    PubMed     Text format     Abstract available


  284. FURIN J, Mafukidze A, Brigden G, du Cros P, et al
    A bitter pill to swallow: the need for better medications for drug-resistant tuberculosis in children.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:55-60.
    PubMed     Text format     Abstract available


  285. BASSYOUNI H, Breugelmans JG, Surette M, Olesen O, et al
    Childhood tuberculosis: a unified response to a global problem.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:54.
    PubMed     Text format    


  286. CRUZ AT, Martinez BJ
    Childhood tuberculosis in the United States: shifting the focus to prevention.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:50-3.
    PubMed     Text format     Abstract available


  287. AMANULLAH F, Malik AA
    Unmasking childhood tuberculosis in Pakistan: efforts to improve detection and management.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:47-9.
    PubMed     Text format     Abstract available


  288. SWAMINATHAN S, Sachdeva KS
    Treatment of childhood tuberculosis in India.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:43-6.
    PubMed     Text format     Abstract available


  289. MALECHE-OBIMBO E, Wanjau W, Kathure I
    The journey to improve the prevention and management of childhood tuberculosis: the Kenyan experience.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:39-42.
    PubMed     Text format     Abstract available


  290. MALHOTRA S, Ursu I, Ghoneim R, Jodrey PP, et al
    From availability to uptake: planning for the introduction of new, child-friendly anti-tuberculosis formulations.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:32-8.
    PubMed     Text format     Abstract available


  291. USHERENKO I, Basu Roy U, Mazlish S, Liu S, et al
    Pediatric tuberculosis drug market: an insider perspective on challenges and solutions.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:23-31.
    PubMed     Text format     Abstract available


  292. SCOTT C, Gardiner E, de Lucia A
    The procurement landscape of pediatric tuberculosis treatment: a Global Drug Facility perspective.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:17-22.
    PubMed     Text format     Abstract available


  293. SEDDON JA, Jenkins HE, Liu L, Cohen T, et al
    Counting children with tuberculosis: why numbers matter.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:9-16.
    PubMed     Text format     Abstract available


  294. GRAHAM SM, Grzemska M, Gie RP
    The background and rationale for a new fixed-dose combination for first-line treatment of tuberculosis in children.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:3-8.
    PubMed     Text format     Abstract available


  295. GOOSBY E
    Out of the shadows: shining a light on children with tuberculosis.
    Int J Tuberc Lung Dis. 2015;19 Suppl 1:1-2.
    PubMed     Text format    


  296. LAWN SD, Kerkhoff AD
    Rapid diagnosis of TB in HIV-positive in-patients with M. tuberculosis bacteraemia in sub-Saharan Africa.
    Int J Tuberc Lung Dis. 2015;19:1557-9.
    PubMed     Text format    


  297. O'CONNOR BD, Woltmann G, Patel H, Turapov O, et al
    Can resuscitation-promoting factors be used to improve culture rates of extra-pulmonary tuberculosis?
    Int J Tuberc Lung Dis. 2015;19:1556-7.
    PubMed     Text format    


  298. REINA S, Silva C, Gaio AR, Correia AM, et al
    HIV screening in tuberculosis patients in the northern region of Portugal.
    Int J Tuberc Lung Dis. 2015;19:1554-5.
    PubMed     Text format    


  299. ARDIZZONI E, Mulders W, Kotrikadze T, Aspindzelashvili R, et al
    The thin-layer agar method for direct phenotypic detection of multi- and extensively drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1547-52.
    PubMed     Text format     Abstract available


  300. CAUSSE M, Ruiz P, Gutierrez JB, Vaquero M, et al
    New Anyplex II MTB/MDR/XDR kit for detection of resistance mutations in M. tuberculosis cultures.
    Int J Tuberc Lung Dis. 2015;19:1542-6.
    PubMed     Text format     Abstract available


  301. MALHOTRA B, Goyal S, Bhargava S, Reddy PV, et al
    Rapid detection of rifampicin resistance in Mycobacterium tuberculosis by high-resolution melting curve analysis.
    Int J Tuberc Lung Dis. 2015;19:1536-41.
    PubMed     Text format     Abstract available


  302. LORENT N, Kong C, Kim T, Sam S, et al
    Systematic screening for drug-resistant tuberculosis with Xpert((R)) MTB/RIF in a referral hospital in Cambodia.
    Int J Tuberc Lung Dis. 2015;19:1528-35.
    PubMed     Text format     Abstract available


  303. GUNTHER G, van Leth F, Altet N, Dedicoat M, et al
    Beyond multidrug-resistant tuberculosis in Europe: a TBNET study.
    Int J Tuberc Lung Dis. 2015;19:1524-7.
    PubMed     Text format     Abstract available


  304. CRUDU V, Merker M, Lange C, Noroc E, et al
    Nosocomial transmission of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1520-3.
    PubMed     Text format     Abstract available


  305. RAMMA L, Cox H, Wilkinson L, Foster N, et al
    Patients' costs associated with seeking and accessing treatment for drug-resistant tuberculosis in South Africa.
    Int J Tuberc Lung Dis. 2015;19:1513-9.
    PubMed     Text format     Abstract available


  306. MORENO-MARTINEZ A, Casals M, Orcau A, Gorrindo P, et al
    Factors associated with diabetes mellitus among adults with tuberculosis in a large European city, 2000-2013.
    Int J Tuberc Lung Dis. 2015;19:1507-12.
    PubMed     Text format     Abstract available


  307. LU MC, Lai CL, Tsai CC, Koo M, et al
    Increased risk of pulmonary and extra-pulmonary tuberculosis in patients with rheumatic diseases.
    Int J Tuberc Lung Dis. 2015;19:1500-6.
    PubMed     Text format     Abstract available


  308. AL-EFRAIJ K, Mota L, Lunny C, Schachter M, et al
    Risk of active tuberculosis in chronic kidney disease: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2015;19:1493-9.
    PubMed     Text format     Abstract available


  309. PAGAOA MA, Royce RA, Chen MP, Golub JE, et al
    Risk factors for transmission of tuberculosis among United States-born African Americans and Whites.
    Int J Tuberc Lung Dis. 2015;19:1485-92.
    PubMed     Text format     Abstract available


  310. CHUNG W, Lee K, Jung Y, Kim Y, et al
    Serum CXCR3 ligands as biomarkers for the diagnosis and treatment monitoring of tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1476-84.
    PubMed     Text format     Abstract available


  311. AMANATIDOU V, Critselis E, Trochoutsou A, Soldatou A, et al
    Interferon gamma inducible protein-10 in the diagnosis of paediatric tuberculosis infection in a low TB incidence country.
    Int J Tuberc Lung Dis. 2015;19:1463-9.
    PubMed     Text format     Abstract available


  312. LU TT, Lin XQ, Zhang L, Cai W, et al
    Magnetic resonance angiography manifestations and prognostic significance in HIV-negative tuberculosis meningitis.
    Int J Tuberc Lung Dis. 2015;19:1448-54.
    PubMed     Text format     Abstract available


  313. WANG Y, Wu JP, Qin GC, Li DY, et al
    Computerised tomography and intravenous pyelography in urinary tuberculosis: a retrospective descriptive study.
    Int J Tuberc Lung Dis. 2015;19:1441-7.
    PubMed     Text format     Abstract available


  314. ALLWOOD BW, Goldin J, Said-Hartley Q, van Zyl-Smit RN, et al
    Assessment of previous tuberculosis status using questionnaires, chest X-rays and computed tomography scans.
    Int J Tuberc Lung Dis. 2015;19:1435-40.
    PubMed     Text format     Abstract available


  315. TRIASIH R, Robertson C, de Campo J, Duke T, et al
    An evaluation of chest X-ray in the context of community-based screening of child tuberculosis contacts.
    Int J Tuberc Lung Dis. 2015;19:1428-34.
    PubMed     Text format     Abstract available


  316. CHANG KC, Yew WW, Sotgiu G
    Clinical research in the treatment of tuberculosis: current status and future prospects.
    Int J Tuberc Lung Dis. 2015;19:1417-27.
    PubMed     Text format     Abstract available


  317. COURTENAY-QUIRK C, Date A, Bachanas P, Baggaley R, et al
    Expanding human immunodeficiency virus testing and counseling to reach tuberculosis clients' partners and families.
    Int J Tuberc Lung Dis. 2015;19:1414-6.
    PubMed     Text format     Abstract available


  318. STOUT JE
    The cost of 'free' tuberculosis care.
    Int J Tuberc Lung Dis. 2015;19:1413.
    PubMed     Text format    


  319. OHKADO A
    How can we sensibly rule out previous episodes of pulmonary tuberculosis disease?
    Int J Tuberc Lung Dis. 2015;19:1412.
    PubMed     Text format    


    November 2015
  320. ABBARA A, Newsholme W, Klein JL, Chambers JB, et al
    Tuberculous endocarditis in an immunocompetent host without miliary tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1407-8.
    PubMed     Text format    


  321. SHEN TC, Lin CL, Wei CC, Chen CH, et al
    Previous history of tuberculosis is associated with rheumatoid arthritis.
    Int J Tuberc Lung Dis. 2015;19:1401-5.
    PubMed     Text format     Abstract available


  322. YU SN, Cho OH, Park KH, Jung J, et al
    Late paradoxical lymph node enlargement during and after anti-tuberculosis treatment in non-HIV-infected patients.
    Int J Tuberc Lung Dis. 2015;19:1388-94.
    PubMed     Text format     Abstract available


  323. MANIKA K, Chatzika K, Papaioannou M, Kontou P, et al
    Rifampicin-moxifloxacin interaction in tuberculosis treatment: a real-life study.
    Int J Tuberc Lung Dis. 2015;19:1383-7.
    PubMed     Text format     Abstract available


  324. HATSUDA K, Takeuchi M, Ogata K, Sasaki Y, et al
    The impact of nutritional state on the duration of sputum positivity of Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1369-75.
    PubMed     Text format     Abstract available


  325. KRIEL M, Lotz JW, Kidd M, Walzl G, et al
    Evaluation of a radiological severity score to predict treatment outcome in adults with pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1354-60.
    PubMed     Text format     Abstract available


  326. SHARMA A, Musau S, Heilig CM, Okumu AO, et al
    Assessing the effect of decentralisation of laboratory diagnosis for drug-resistant tuberculosis in Kenya.
    Int J Tuberc Lung Dis. 2015;19:1348-53.
    PubMed     Text format     Abstract available


  327. MARANGU D, Devine B, John-Stewart G
    Diagnostic accuracy of nucleic acid amplification tests in urine for pulmonary tuberculosis: a meta-analysis.
    Int J Tuberc Lung Dis. 2015;19:1339-47.
    PubMed     Text format     Abstract available


  328. COLVIN CJ, Leon N, Wills C, van Niekerk M, et al
    Global-to-local policy transfer in the introduction of new molecular tuberculosis diagnostics in South Africa.
    Int J Tuberc Lung Dis. 2015;19:1326-38.
    PubMed     Text format     Abstract available


  329. DOS SANTOS DIAS E, do Prado TN, da Silva Guimaraes AL, Ramos MC, et al
    Childhood tuberculosis and human immunodeficiency virus status in Brazil: a hierarchical analysis.
    Int J Tuberc Lung Dis. 2015;19:1305-11.
    PubMed     Text format     Abstract available


  330. KAWATSU L, Izumi K, Uchimura K, Urakawa M, et al
    Can social network analysis assist in the prioritisation of contacts in a tuberculosis contact investigation?
    Int J Tuberc Lung Dis. 2015;19:1293-9.
    PubMed     Text format     Abstract available


  331. ZHANG Y, Yew WW
    Mechanisms of drug resistance in Mycobacterium tuberculosis: update 2015.
    Int J Tuberc Lung Dis. 2015;19:1276-89.
    PubMed     Text format     Abstract available


  332. ZACHARIAH R, Ortuno N, Hermans V, Desalegn W, et al
    Ebola, fragile health systems and tuberculosis care: a call for pre-emptive action and operational research.
    Int J Tuberc Lung Dis. 2015;19:1271-5.
    PubMed     Text format     Abstract available


  333. SLOAN DJ, O'Dempsey TJ
    Tuberculosis in the time of Ebola: obstacles and opportunities.
    Int J Tuberc Lung Dis. 2015;19:1269.
    PubMed     Text format    


  334. TREBUCQ A, Devi S
    Widespread use of Xpert((R)) MTB/RIF will most probably reduce the total number of TB cases notified.
    Int J Tuberc Lung Dis. 2015;19:1406.
    PubMed     Text format    


  335. CRESWELL J, Rai B, Codlin AJ
    In reply.
    Int J Tuberc Lung Dis. 2015;19:1406-7.
    PubMed     Text format    


    October 2015
  336. VOLZ MS, Loddenkemper C, Morguet A, Moos V, et al
    Cardiac myxoma secreting interleukin-6 promotes cavitary tuberculosis: a case report.
    Int J Tuberc Lung Dis. 2015;19:1265-6.
    PubMed     Text format    


  337. NUNN AJ, Phillips PP, Abubakar I
    Reducing relapse in tuberculosis treatment.
    Int J Tuberc Lung Dis. 2015;19:1263-4.
    PubMed     Text format    


  338. GUPTA R, Geiter LJ, Hafkin J, Wells CD, et al
    Delamanid and QT prolongation in the treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1261-2.
    PubMed     Text format    


  339. PAINTER JA, Posey DL, Phares C
    Tuberculosis misclassification among immigrants.
    Int J Tuberc Lung Dis. 2015;19:1259-60.
    PubMed     Text format    


  340. DENHOLM JT, Matteelli A, Reis A
    In reply. Promoting ethical and evidence-based policies for latent tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1258-9.
    PubMed     Text format    


  341. LI N, Xie WP, Kong H, Min R, et al
    Enrichment of regulatory T-cells in blood of patients with multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1230-8.
    PubMed     Text format     Abstract available


  342. KAMBLI P, Ajbani K, Nikam C, Khillari A, et al
    Determination of MICs of levofloxacin for Mycobacterium tuberculosis with gyrA mutations.
    Int J Tuberc Lung Dis. 2015;19:1227-9.
    PubMed     Text format     Abstract available


  343. ELMARAACHLI W, Slater M, Berrada ZL, Lin SY, et al
    Predicting differential rifamycin resistance in clinical Mycobacterium tuberculosis isolates by specific rpoB mutations.
    Int J Tuberc Lung Dis. 2015;19:1222-6.
    PubMed     Text format     Abstract available


  344. KIM YW, Seong MW, Kim TS, Yoo CG, et al
    Evaluation of Xpert((R)) MTB/RIF assay: diagnosis and treatment outcomes in rifampicin-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1216-21.
    PubMed     Text format     Abstract available


  345. TU HZ, Lin YE, Tseng MR, Huang TS, et al
    Cost-effective identification of Mycobacterium tuberculosis complex using microscopic morphology and rapid tests.
    Int J Tuberc Lung Dis. 2015;19:1204-8.
    PubMed     Text format     Abstract available


  346. ADELMAN MW, Tsegaye M, Kempker RR, Alebachew T, et al
    Intensified tuberculosis case finding among HIV-infected persons using a WHO symptom screen and Xpert((R)) MTB/RIF.
    Int J Tuberc Lung Dis. 2015;19:1197-203.
    PubMed     Text format     Abstract available


  347. REIS-SANTOS B, Pellacani-Posses I, Macedo LR, Golub JE, et al
    Directly observed therapy of tuberculosis in Brazil: associated determinants and impact on treatment outcome.
    Int J Tuberc Lung Dis. 2015;19:1188-93.
    PubMed     Text format     Abstract available


  348. VALENCA MS, Scaini JL, Abileira FS, Goncalves CV, et al
    Prevalence of tuberculosis in prisons: risk factors and molecular epidemiology.
    Int J Tuberc Lung Dis. 2015;19:1182-7.
    PubMed     Text format     Abstract available


  349. KOSGEI RJ, Sitienei JK, Kipruto H, Kimenye K, et al
    Gender differences in treatment outcomes among 15-49 year olds with smear-positive pulmonary tuberculosis in Kenya.
    Int J Tuberc Lung Dis. 2015;19:1176-81.
    PubMed     Text format     Abstract available


  350. KAMPER-JORGENSEN Z, Carstensen B, Norredam M, Bygbjerg IC, et al
    Diabetes-related tuberculosis in Denmark: effect of ethnicity, diabetes duration and year of diagnosis.
    Int J Tuberc Lung Dis. 2015;19:1169-75.
    PubMed     Text format     Abstract available


  351. SHIDAM UG, Roy G, Sahu SK, Kumar SV, et al
    Screening for diabetes among presumptive tuberculosis patients at a tertiary care centre in Pondicherry, India.
    Int J Tuberc Lung Dis. 2015;19:1163-8.
    PubMed     Text format     Abstract available


  352. MUKHERJEE A, Khandelwal D, Singla M, Lodha R, et al
    Outcomes of Category II anti-tuberculosis treatment in Indian children.
    Int J Tuberc Lung Dis. 2015;19:1153-7.
    PubMed     Text format     Abstract available


  353. CHIANG SS, Roche S, Contreras C, Alarcon V, et al
    Barriers to the diagnosis of childhood tuberculosis: a qualitative study.
    Int J Tuberc Lung Dis. 2015;19:1144-52.
    PubMed     Text format     Abstract available


  354. MASON PH, Degeling C, Denholm J
    Sociocultural dimensions of tuberculosis: an overview of key concepts.
    Int J Tuberc Lung Dis. 2015;19:1135-43.
    PubMed     Text format     Abstract available


  355. SOTGIU G, Matteelli A, Migliori GB
    Diabetes and tuberculosis: what else beyond?
    Int J Tuberc Lung Dis. 2015;19:1127-8.
    PubMed     Text format    


  356. STEVENSON DR, Biswas JR, Lievesley A, Quinn G, et al
    False-positive Xpert((R)) MTB/RIF more than seven years after cure.
    Int J Tuberc Lung Dis. 2015;19:1264-5.
    PubMed     Text format    


  357. EVANS TB, Mador MJ, Glick M
    In reply.
    Int J Tuberc Lung Dis. 2015;19:1260-1.
    PubMed     Text format    


  358. NOESKE J
    Sovereignty or dignity?
    Int J Tuberc Lung Dis. 2015;19:1258.
    PubMed     Text format    


  359. FURIN J, Harausz E, Zimetbaum P, Cox H, et al
    In reply. QTc prolongation and delamanid: access and safety.
    Int J Tuberc Lung Dis. 2015;19:1262-3.
    PubMed     Text format    


  360. JOHNSTON JC, Khan FA, Dowdy DW
    In reply.
    Int J Tuberc Lung Dis. 2015;19:1264.
    PubMed     Text format    


    September 2015
  361. ATRE S
    Notification of multidrug-resistant tuberculosis cases and treatment outcomes in the private sector.
    Int J Tuberc Lung Dis. 2015;19:1126.
    PubMed     Text format    


  362. RATNAPPULI A, Collinson S, Gaspar-Garcia E, Richardson L, et al
    Pott's disease in twenty-first century London: spinal tuberculosis as a continuing cause of morbidity and mortality.
    Int J Tuberc Lung Dis. 2015;19:1125-6.
    PubMed     Text format    


  363. SUEN SC, Bendavid E, Goldhaber-Fiebert JD
    Cost-effectiveness of improvements in diagnosis and treatment accessibility for tuberculosis control in India.
    Int J Tuberc Lung Dis. 2015;19:1115-24.
    PubMed     Text format     Abstract available


  364. CHOI Y, Hong SR, Jeon BY, Wang HY, et al
    Conventional and real-time PCR targeting 16S ribosomal RNA for the detection of Mycobacterium tuberculosis complex.
    Int J Tuberc Lung Dis. 2015;19:1102-8.
    PubMed     Text format     Abstract available


  365. HEO EY, Choi NK, Yang BR, Koo BK, et al
    Tuberculosis is frequently diagnosed within 12 months of diabetes mellitus.
    Int J Tuberc Lung Dis. 2015;19:1098-101.
    PubMed     Text format     Abstract available


  366. TOGUN TO, Egere U, Sillah AK, Ayorinde A, et al
    Contribution of Xpert((R)) MTB/RIF to the diagnosis of pulmonary tuberculosis among TB-exposed children in The Gambia.
    Int J Tuberc Lung Dis. 2015;19:1091-7.
    PubMed     Text format     Abstract available


  367. PAGE AL, Ardizzoni E, Lassovsky M, Kirubi B, et al
    Routine use of Xpert((R)) MTB/RIF in areas with different prevalences of HIV and drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:1078-83.
    PubMed     Text format     Abstract available


  368. BASU I, Bower JE, Henderson GK, Lowe O, et al
    False-negative BD MGIT TBc Identification Test results in routine tuberculosis diagnosis: a New Zealand perspective.
    Int J Tuberc Lung Dis. 2015;19:1073-5.
    PubMed     Text format     Abstract available


  369. HERNANDEZ P, Punchak M, Camacho M, Hepple P, et al
    Investigating the quality of expectorated sputum for tuberculosis diagnosis in Bolivia.
    Int J Tuberc Lung Dis. 2015;19:1065-7.
    PubMed     Text format     Abstract available


  370. GARFEIN RS, Collins K, Munoz F, Moser K, et al
    Feasibility of tuberculosis treatment monitoring by video directly observed therapy: a binational pilot study.
    Int J Tuberc Lung Dis. 2015;19:1057-64.
    PubMed     Text format     Abstract available


  371. SITIENEI J, Kipruto H, Mansour O, Ndisha M, et al
    Correlates of default from anti-tuberculosis treatment: a case study using Kenya's electronic data system.
    Int J Tuberc Lung Dis. 2015;19:1051-6.
    PubMed     Text format     Abstract available


  372. SALYER SJ, Fitter DL, Milo R, Blanton C, et al
    Evaluation of the national tuberculosis surveillance program in Haiti.
    Int J Tuberc Lung Dis. 2015;19:1045-50.
    PubMed     Text format     Abstract available


  373. MORALES-GARCIA C, Parra-Ruiz J, Sanchez-Martinez JA, Delgado-Martin AE, et al
    Concomitant tuberculosis and lung cancer diagnosed by bronchoscopy.
    Int J Tuberc Lung Dis. 2015;19:1027-32.
    PubMed     Text format     Abstract available


  374. DEDICOAT M, Lange C
    Tuberculosis preventive chemotherapy: the times they are a-changin'.
    Int J Tuberc Lung Dis. 2015;19:1002.
    PubMed     Text format    


    August 2015
  375. REMASCHI G, Venturini E, Romano F, Perrone A, et al
    A rare cause of osteomyelitis with a rare genetic mutation: when Mycobacterium doesn't only mean tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:999-1000.
    PubMed     Text format    


  376. JOON D, Nimesh M, Saluja D
    Loop-mediated isothermal amplification as alternative to PCR for the diagnosis of extra-pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:986-91.
    PubMed     Text format     Abstract available


  377. NDJEKA N, Conradie F, Schnippel K, Hughes J, et al
    Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis.
    Int J Tuberc Lung Dis. 2015;19:979-85.
    PubMed     Text format     Abstract available


  378. DU TOIT E, Squire SB, Dunbar R, Machekano R, et al
    Comparing multidrug-resistant tuberculosis patient costs under molecular diagnostic algorithms in South Africa.
    Int J Tuberc Lung Dis. 2015;19:960-8.
    PubMed     Text format     Abstract available


  379. ASANTE-POKU A, Otchere ID, Danso E, Mensah DD, et al
    Evaluation of GenoType((R)) MTBDRplus for the rapid detection of drug-resistant tuberculosis in Ghana.
    Int J Tuberc Lung Dis. 2015;19:954-9.
    PubMed     Text format     Abstract available


  380. HIRSCH-MOVERMAN Y, Cronin WA, Chen B, Moran JA, et al
    HIV counseling and testing in tuberculosis contact investigations in the United States and Canada.
    Int J Tuberc Lung Dis. 2015;19:943-53.
    PubMed     Text format     Abstract available


  381. LAI CC, Lee MT, Lee SH, Lee SH, et al
    Risk of incident active tuberculosis and use of corticosteroids.
    Int J Tuberc Lung Dis. 2015;19:936-42.
    PubMed     Text format     Abstract available


  382. KAWATSU L, Uchimura K, Kobayashi M, Ishikawa N, et al
    Overview of the tuberculosis burden in prison institutions in Japan, 2000-2012.
    Int J Tuberc Lung Dis. 2015;19:921-6.
    PubMed     Text format     Abstract available


  383. IWATA K, Doi A, Nakamura T, Yoshida H, et al
    The validity of three sputum smears taken in one day for discontinuing isolation of tuberculosis patients.
    Int J Tuberc Lung Dis. 2015;19:918-20.
    PubMed     Text format     Abstract available


  384. SHETE PB, Haguma P, Miller CR, Ochom E, et al
    Pathways and costs of care for patients with tuberculosis symptoms in rural Uganda.
    Int J Tuberc Lung Dis. 2015;19:912-7.
    PubMed     Text format     Abstract available


  385. SLOAN DJ, Mwandumba HC, Kamdolozi M, Shani D, et al
    Vitamin D deficiency in Malawian adults with pulmonary tuberculosis: risk factors and treatment outcomes.
    Int J Tuberc Lung Dis. 2015;19:904-11.
    PubMed     Text format     Abstract available


  386. JERENE D, Melese M, Kassie Y, Alem G, et al
    The yield of a tuberculosis household contact investigation in two regions of Ethiopia.
    Int J Tuberc Lung Dis. 2015;19:898-903.
    PubMed     Text format     Abstract available


  387. HARRIES AD, Kumar AM, Satyanarayana S, Lin Y, et al
    Diabetes mellitus and tuberculosis: programmatic management issues.
    Int J Tuberc Lung Dis. 2015;19:879-86.
    PubMed     Text format     Abstract available


  388. DAVIES PD, Martineau AR
    Vitamin D and tuberculosis: more effective in prevention than treatment?
    Int J Tuberc Lung Dis. 2015;19:876-7.
    PubMed     Text format    


  389. DAVIES PD
    Towards the elimination of tuberculosis and a reduction in chest diseases.
    Int J Tuberc Lung Dis. 2015;19:875.
    PubMed     Text format    


    July 2015
  390. VOLZ MS, Epple HJ, Schneider T
    Immune reconstitution inflammatory syndrome after BCG infection mimicking miliary tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:873-4.
    PubMed     Text format    


  391. BALAJEE KL, Rizwan SA, Kulkarni V, Silan V, et al
    Fixed-dose combination drugs for the treatment of tuberculosis under India's RNTCP.
    Int J Tuberc Lung Dis. 2015;19:870-1.
    PubMed     Text format    


  392. KOWADA A
    Cost-effectiveness of tobacco cessation support combined with tuberculosis screening among contacts who smoke.
    Int J Tuberc Lung Dis. 2015;19:857-63.
    PubMed     Text format     Abstract available


  393. ROBERTS-WITTEVEEN A, Reinten T, Christensen A, Sintchenko V, et al
    Multidrug-resistant tuberculosis in New South Wales, Australia, 1999-2010: a case series report.
    Int J Tuberc Lung Dis. 2015;19:850-6.
    PubMed     Text format     Abstract available


  394. LI CP, Zhou Y, Xiang X, Zhou Y, et al
    Relationship of HLA-DRB1 gene polymorphism with susceptibility to pulmonary tuberculosis: updated meta-analysis.
    Int J Tuberc Lung Dis. 2015;19:841-9.
    PubMed     Text format     Abstract available


  395. KAMUDUMULI PS, Beylis N, Blann L, Duse A, et al
    Molecular typing of drug-susceptible and -resistant Mycobacterium tuberculosis in Johannesburg, South Africa.
    Int J Tuberc Lung Dis. 2015;19:834-40.
    PubMed     Text format     Abstract available


  396. JUBULIS J, Dionne K, Osterhout G, Ayuk L, et al
    Mycobacterium tuberculosis resistance in pulmonary TB patients in Cameroon: a phenotypic susceptibility assay.
    Int J Tuberc Lung Dis. 2015;19:823-7.
    PubMed     Text format     Abstract available


  397. RIENTHONG S, Boonin C, Chaiyasirinrote B, Satproedprai N, et al
    Evaluation of a novel line-probe assay for genotyping-based diagnosis of Mycobacterium tuberculosis in Thailand.
    Int J Tuberc Lung Dis. 2015;19:817-22.
    PubMed     Text format     Abstract available


  398. DE LA MORA IL, Martinez-Oceguera D, Laniado-Laborin R
    Chronic airway obstruction after successful treatment of tuberculosis and its impact on quality of life.
    Int J Tuberc Lung Dis. 2015;19:808-10.
    PubMed     Text format     Abstract available


  399. HEMANTH KUMAR AK, Narendran G, Kumar RS, Ramachandran G, et al
    RMP exposure is lower in HIV-infected TB patients receiving intermittent than daily anti-tuberculosis treatment.
    Int J Tuberc Lung Dis. 2015;19:805-7.
    PubMed     Text format     Abstract available


  400. JONNALAGADDA S, LaCourse SM, Otieno P, Lohman-Payne B, et al
    Incidence and correlates of tuberculosis IGRA conversion among HIV-infected postpartum women.
    Int J Tuberc Lung Dis. 2015;19:792-8.
    PubMed     Text format     Abstract available


  401. ZHANG XL, Li SG, Li HT, Li GX, et al
    Integrating tuberculosis screening into annual health examinations for the rural elderly improves case detection.
    Int J Tuberc Lung Dis. 2015;19:787-91.
    PubMed     Text format     Abstract available


  402. DAWSON R, Narunsky K, Carman D, Gupte N, et al
    Two-stage activity-safety study of daily rifapentine during intensive phase treatment of pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:780-6.
    PubMed     Text format     Abstract available


  403. GAO Z, Parhar A, Gallant V, Heffernan C, et al
    A population-based study of tuberculosis case fatality in Canada: do Aboriginal peoples fare less well?
    Int J Tuberc Lung Dis. 2015;19:772-9.
    PubMed     Text format     Abstract available


  404. LIEW SM, Khoo EM, Ho BK, Lee YK, et al
    Tuberculosis in Malaysia: predictors of treatment outcomes in a national registry.
    Int J Tuberc Lung Dis. 2015;19:764-71.
    PubMed     Text format     Abstract available


  405. SATYANARAYANA S, Subbaraman R, Shete P, Gore G, et al
    Quality of tuberculosis care in India: a systematic review.
    Int J Tuberc Lung Dis. 2015;19:751-63.
    PubMed     Text format     Abstract available


  406. ADAMS CD, Velez JD, Martinez LF
    Xpert((R)) MTB/RIF and very low positive detection in bronchoalveolar lavage: diagnostic concerns.
    Int J Tuberc Lung Dis. 2015;19:871-3.
    PubMed     Text format    


  407. SIMONS SO, van der Laan T, de Zwaan R, Kamst M, et al
    Molecular drug susceptibility testing in the Netherlands: performance of the MTBDRplus and MTBDRsl assays.
    Int J Tuberc Lung Dis. 2015;19:828-33.
    PubMed     Text format     Abstract available


  408. HANRAHAN CF, Clouse K, Bassett J, Mutunga L, et al
    The patient impact of point-of-care vs. laboratory placement of Xpert((R)) MTB/RIF.
    Int J Tuberc Lung Dis. 2015;19:811-6.
    PubMed     Text format     Abstract available


  409. BISHARA H, Ore L, Vinitsky O, Bshara H, et al
    Cost of nurse-managed latent tuberculous infection treatment among hard-to-reach immigrants in Israel.
    Int J Tuberc Lung Dis. 2015;19:799-804.
    PubMed     Text format     Abstract available


    June 2015
  410. PADBERG I, Batzing-Feigenbaum J, Sagebiel D
    Association of extra-pulmonary tuberculosis with age, sex and season differs depending on the affected organ.
    Int J Tuberc Lung Dis. 2015;19:723-8.
    PubMed     Text format     Abstract available


  411. CHEN LM, Liu YQ, Shen JN, Peng YL, et al
    The 100 top-cited tuberculosis research studies.
    Int J Tuberc Lung Dis. 2015;19:717-22.
    PubMed     Text format     Abstract available


  412. O'HARA GA, Abdullah S, Creer DD, Elsaghier AF, et al
    Cord formation in BACTEC(TM) medium aids rapid identification of Mycobacterium tuberculosis complex.
    Int J Tuberc Lung Dis. 2015;19:709-10.
    PubMed     Text format     Abstract available


  413. OH JY, Sim JK, Jung WJ, Min KH, et al
    Association between interleukin-27 polymorphisms and pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:702-8.
    PubMed     Text format     Abstract available


  414. KELLY V, Sagili KD, Satyanarayana S, Reza LW, et al
    Cost-utility analysis of LED fluorescence microscopy in the diagnosis of pulmonary tuberculosis in Indian settings.
    Int J Tuberc Lung Dis. 2015;19:696-701.
    PubMed     Text format     Abstract available


  415. MUSAU S, McCarthy K, Okumu A, Shinnick T, et al
    Experience in implementing a quality management system in a tuberculosis laboratory, Kisumu, Kenya.
    Int J Tuberc Lung Dis. 2015;19:693-5.
    PubMed     Text format     Abstract available


  416. MAGEE MJ, Kempker RR, Kipiani M, Gandhi NR, et al
    Diabetes mellitus is associated with cavities, smear grade, and multidrug-resistant tuberculosis in Georgia.
    Int J Tuberc Lung Dis. 2015;19:685-92.
    PubMed     Text format     Abstract available


  417. ALAME-EMANE AK, Xu P, Pierre-Audigier C, Cadet-Daniel V, et al
    Pyrazinamide resistance in Mycobacterium tuberculosis arises after rifampicin and fluoroquinolone resistance.
    Int J Tuberc Lung Dis. 2015;19:679-84.
    PubMed     Text format     Abstract available


  418. NHUNG NV, Hoa NB, Sy DN, Hennig CM, et al
    The fourth national anti-tuberculosis drug resistance survey in viet nam.
    Int J Tuberc Lung Dis. 2015;19:670-5.
    PubMed     Text format     Abstract available


  419. MOORE BK, Anyalechi E, van der Walt M, Smith S, et al
    Epidemiology of drug-resistant tuberculosis among children and adolescents in South Africa, 2005-2010.
    Int J Tuberc Lung Dis. 2015;19:663-9.
    PubMed     Text format     Abstract available


  420. DOBLER CC, Korver S, Batbayar O, Oyuntsetseg S, et al
    Success of community-based directly observed anti-tuberculosis treatment in Mongolia.
    Int J Tuberc Lung Dis. 2015;19:657-62.
    PubMed     Text format     Abstract available


  421. FATIMA R, Qadeer E, Hinderaker SG, Yaqoob A, et al
    Can the number of patients with presumptive tuberculosis lost in the general health services in Pakistan be reduced?
    Int J Tuberc Lung Dis. 2015;19:654-6.
    PubMed     Text format     Abstract available


  422. SENKORO M, Hinderaker SG, Mfinanga SG, Range N, et al
    Health care-seeking behaviour among people with cough in Tanzania: findings from a tuberculosis prevalence survey.
    Int J Tuberc Lung Dis. 2015;19:640-6.
    PubMed     Text format     Abstract available


  423. SUBRAMANI R, Kolappan C, Chandrasekaran V, Selvakumar N, et al
    Could repeated prevalence surveys lead to decreasing tuberculosis prevalence in a community?
    Int J Tuberc Lung Dis. 2015;19:635-9.
    PubMed     Text format     Abstract available


  424. DAVIES GR, Phillips PP, Jaki T
    Adaptive clinical trials in tuberculosis: applications, challenges and solutions.
    Int J Tuberc Lung Dis. 2015;19:626-34.
    PubMed     Text format     Abstract available


  425. SEDDON JA
    Time to be a bit more 'surgical' in our management of children with drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:625.
    PubMed     Text format    


  426. JOHNSTON JC, Khan FA, Dowdy DW
    Reducing relapse in tuberculosis treatment: is it time to reassess WHO treatment guidelines?
    Int J Tuberc Lung Dis. 2015;19:624.
    PubMed     Text format    


  427. GETAHUN H, Varma J
    Transitioning from 'stopping' to 'ending' the tuberculosis epidemic.
    Int J Tuberc Lung Dis. 2015;19:623-4.
    PubMed     Text format    


  428. BABLISHVILI N, Tukvadze N, Avaliani Z, Blumberg HM, et al
    A comparison of the Xpert((R)) MTB/RIF and GenoType((R)) MTBDRplus assays in Georgia.
    Int J Tuberc Lung Dis. 2015;19:676-8.
    PubMed     Text format     Abstract available


  429. MCCARTHY KM, Scott LE, Gous N, Tellie M, et al
    High incidence of latent tuberculous infection among South African health workers: an urgent call for action.
    Int J Tuberc Lung Dis. 2015;19:647-53.
    PubMed     Text format     Abstract available


    May 2015
  430. NAIK BR, Shastri SG, Vishwanath NS, Suryakanth MD, et al
    Adverse drug reactions in tuberculosis patients: consequences for TB control.
    Int J Tuberc Lung Dis. 2015;19:621-2.
    PubMed     Text format    


  431. JAFTA N, Jeena PM, Barregard L, Naidoo RN, et al
    Childhood tuberculosis and exposure to indoor air pollution: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2015;19:596-602.
    PubMed     Text format     Abstract available


  432. KO Y, Lee YM, Lee HY, Lee YS, et al
    Changes in lung function according to disease extent before and after pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:589-95.
    PubMed     Text format     Abstract available


  433. CHOI JC, Jarlsberg LG, Grinsdale JA, Osmond DH, et al
    Reduced sensitivity of the QuantiFERON((R)) test in diabetic patients with smear-negative tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:582-8.
    PubMed     Text format     Abstract available


  434. KIM HJ, Lee GH, Ryoo S, Oh SY, et al
    Role of confirmatory interferon-gamma release assays in school outbreaks of tuberculosis in South Korea.
    Int J Tuberc Lung Dis. 2015;19:576-81.
    PubMed     Text format     Abstract available


  435. ATWINE D, Nansumba M, Orikiriza P, Riera M, et al
    Intra-gastric string test: an effective tool for diagnosing tuberculosis in adults unable to produce sputum.
    Int J Tuberc Lung Dis. 2015;19:558-64.
    PubMed     Text format     Abstract available


  436. DAUM LT, Peters RP, Fourie PB, Jonkman K, et al
    Molecular detection of Mycobacterium tuberculosis from sputum transported in PrimeStore((R)) from rural settings.
    Int J Tuberc Lung Dis. 2015;19:552-7.
    PubMed     Text format     Abstract available


  437. CRESWELL J, Rai B, Wali R, Sudrungrot S, et al
    Introducing new tuberculosis diagnostics: the impact of Xpert((R)) MTB/RIF testing on case notifications in Nepal.
    Int J Tuberc Lung Dis. 2015;19:545-51.
    PubMed     Text format     Abstract available


  438. HO J, Marks GB, Fox GJ
    The impact of sputum quality on tuberculosis diagnosis: a systematic review.
    Int J Tuberc Lung Dis. 2015;19:537-44.
    PubMed     Text format     Abstract available


  439. DA S GARRIDO M, Buhrer-Sekula S, Souza AB, de Oliveira GP, et al
    Multidrug-resistant tuberculosis in the Amazonas State, Brazil, 2000-2011.
    Int J Tuberc Lung Dis. 2015;19:531-6.
    PubMed     Text format     Abstract available


  440. KWAK N, Kim HR, Yoo CG, Kim YW, et al
    Changes in treatment outcomes of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:525-30.
    PubMed     Text format     Abstract available


  441. DORMAN S
    Advances in the diagnosis of tuberculosis: current status and future prospects.
    Int J Tuberc Lung Dis. 2015;19:504-16.
    PubMed     Text format     Abstract available


  442. MURRAY JF
    The Industrial Revolution and the decline in death rates from tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:502-3.
    PubMed     Text format    


  443. NUERMBERGER E, Yew WW
    Expanding the evidence base supporting shorter treatment durations for multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:497-8.
    PubMed     Text format    


  444. RASHID ALI MR, Parameswaran U, William T, Bird E, et al
    A prospective study of mycobacterial viability in refrigerated, unpreserved sputum batched for up to 8 weeks.
    Int J Tuberc Lung Dis. 2015;19:620-1.
    PubMed     Text format    


  445. MUNN MS, Duchin JS, Kay M, Pecha M, et al
    Analysis of risk factors for tuberculous infection following exposure at a homeless shelter.
    Int J Tuberc Lung Dis. 2015;19:570-5.
    PubMed     Text format     Abstract available


  446. SUBEDI P, Drezner KA, Dogbey MC, Newbern EC, et al
    Evaluation of latent tuberculous infection and treatment completion for refugees in Philadelphia, PA, 2010-2012.
    Int J Tuberc Lung Dis. 2015;19:565-9.
    PubMed     Text format     Abstract available


  447. KUABAN C, Noeske J, Rieder HL, Ait-Khaled N, et al
    High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon.
    Int J Tuberc Lung Dis. 2015;19:517-24.
    PubMed     Text format     Abstract available


  448. YEW WW, Chiang CY, Lumb R, Islam T, et al
    Are pulmonary non-tuberculous mycobacteria of concern in the Western Pacific Region?
    Int J Tuberc Lung Dis. 2015;19:499-500.
    PubMed     Text format    


    April 2015
  449. DUDNYK A, Rzhepishevska O, Rogach K, Kutsyna G, et al
    Multidrug-resistant tuberculosis in Ukraine at a time of military conflict.
    Int J Tuberc Lung Dis. 2015;19:492-3.
    PubMed     Text format    


  450. CHU NH, Li L, Zhang X, Gu J, et al
    Role of bicyclol in preventing drug-induced liver injury in tuberculosis patients with liver disease.
    Int J Tuberc Lung Dis. 2015;19:475-80.
    PubMed     Text format     Abstract available


  451. JAFARI-KOSHKI T, Arsang-Jang S, Raei M
    Applying spatiotemporal models to study risk of smear-positive tuberculosis in Iran, 2001-2012.
    Int J Tuberc Lung Dis. 2015;19:469-74.
    PubMed     Text format     Abstract available


  452. JOHN S, Gidado M, Dahiru T, Fanning A, et al
    Tuberculosis among nomads in Adamawa, Nigeria: outcomes from two years of active case finding.
    Int J Tuberc Lung Dis. 2015;19:463-8.
    PubMed     Text format     Abstract available


  453. WISEMAN CA, Mandalakas AM, Kirchner HL, Gie RP, et al
    Novel application of NIH case definitions in a paediatric tuberculosis contact investigation study.
    Int J Tuberc Lung Dis. 2015;19:446-53.
    PubMed     Text format     Abstract available


  454. ARYA A, Roy V, Lomash A, Kapoor S, et al
    Rifampicin pharmacokinetics in children under the Revised National Tuberculosis Control Programme, India, 2009.
    Int J Tuberc Lung Dis. 2015;19:440-5.
    PubMed     Text format     Abstract available


  455. CHAIDIR L, Sengstake S, de Beer J, Krismawati H, et al
    Mycobacterium tuberculosis genotypic drug resistance patterns and clustering in Jayapura, Papua, Indonesia.
    Int J Tuberc Lung Dis. 2015;19:428-33.
    PubMed     Text format     Abstract available


  456. GARFEIN RS, Catanzaro DG, Rodwell TC, Avalos E, et al
    Phenotypic and genotypic diversity in a multinational sample of drug-resistant Mycobacterium tuberculosis isolates.
    Int J Tuberc Lung Dis. 2015;19:420-7.
    PubMed     Text format     Abstract available


  457. WEI XL, Yin J, Zou GY, Zhang ZT, et al
    Treatment interruption and directly observed treatment of multidrug-resistant tuberculosis patients in China.
    Int J Tuberc Lung Dis. 2015;19:413-9.
    PubMed     Text format     Abstract available


  458. VAN ALTENA R, de Vries G, Haar CH, de Lange WC, et al
    Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000-2009.
    Int J Tuberc Lung Dis. 2015;19:406-12.
    PubMed     Text format     Abstract available


  459. GELMANOVA IY, Ahmad Khan F, Becerra MC, Zemlyanaya NA, et al
    Low rates of recurrence after successful treatment of multidrug-resistant tuberculosis in Tomsk, Russia.
    Int J Tuberc Lung Dis. 2015;19:399-405.
    PubMed     Text format     Abstract available


  460. HARAUSZ E, Cox H, Rich M, Mitnick CD, et al
    QTc prolongation and treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:385-91.
    PubMed     Text format     Abstract available


  461. BARRERA E, Livchits V, Nardell E
    F-A-S-T: a refocused, intensified, administrative tuberculosis transmission control strategy.
    Int J Tuberc Lung Dis. 2015;19:381-4.
    PubMed     Text format    


  462. ANDREWS JR, Basu S, Dowdy DW, Murray MB, et al
    The epidemiological advantage of preferential targeting of tuberculosis control at the poor.
    Int J Tuberc Lung Dis. 2015;19:375-80.
    PubMed     Text format     Abstract available


  463. DANIEL TM, Iversen PA
    Hippocrates and tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:373-4.
    PubMed     Text format    


  464. REVES RR
    In reply.
    Int J Tuberc Lung Dis. 2015;19:495.
    PubMed     Text format    


  465. BOYLES TH, Hughes J, Cox V, Burton R, et al
    False-positive Xpert((R)) MTB/RIF assays and previous treatment.
    Int J Tuberc Lung Dis. 2015;19:495-6.
    PubMed     Text format    


  466. PHILLIPS PP, Lipman MC
    Safe and effective treatment for patients with isoniazid drug resistance.
    Int J Tuberc Lung Dis. 2015;19:494-5.
    PubMed     Text format    


  467. ZELLWEGER JP, Bodmer T, Bischler U, Mykychak M, et al
    Implementation of the Stop TB strategy in a large TB hospital in Ukraine: achievements and deficiencies.
    Int J Tuberc Lung Dis. 2015;19:493-4.
    PubMed     Text format    


  468. HESSELING AC, Jaspan HB, Black GF, Nene N, et al
    Immunogenicity of BCG in HIV-exposed and non-exposed infants following routine birth or delayed vaccination.
    Int J Tuberc Lung Dis. 2015;19:454-62.
    PubMed     Text format     Abstract available


  469. KUMAR P, Kumar P, Balooni V, Singh S, et al
    Genetic mutations associated with rifampicin and isoniazid resistance in MDR-TB patients in North-West India.
    Int J Tuberc Lung Dis. 2015;19:434-9.
    PubMed     Text format     Abstract available


  470. VAN DEN HANDEL T, Hampton KH, Sanne I, Stevens W, et al
    The impact of Xpert((R)) MTB/RIF in sparsely populated rural settings.
    Int J Tuberc Lung Dis. 2015;19:392-8.
    PubMed     Text format     Abstract available


  471. YIM JJ, Koh WJ
    MDR-TB recurrence after successful treatment: additional studies using molecular genotyping are needed.
    Int J Tuberc Lung Dis. 2015;19:371.
    PubMed     Text format    


    March 2015
  472. FLORES-SUAREZ LF, Saldarriaga Rivera LM, Rivera Rosales RM, Ruiz N, et al
    Cavitary tuberculosis and tracheal stenosis simulating granulomatosis with polyangiitis.
    Int J Tuberc Lung Dis. 2015;19:369-70.
    PubMed     Text format    


  473. VERMA S, Verma G, Singh DV, Mokta J, et al
    Dual infection with pulmonary tuberculosis and Lophomonas blattarum in India.
    Int J Tuberc Lung Dis. 2015;19:368-9.
    PubMed     Text format    


  474. LALLI M, Houben R, Churchyard G, White RG, et al
    Regarding the effect of cured tuberculosis disease on longevity.
    Int J Tuberc Lung Dis. 2015;19:367.
    PubMed     Text format    


  475. FARHAT MR, Mitnick CD, Franke MF, Kaur D, et al
    Concordance of Mycobacterium tuberculosis fluoroquinolone resistance testing: implications for treatment.
    Int J Tuberc Lung Dis. 2015;19:339-41.
    PubMed     Text format     Abstract available


  476. RICKS PM, Hershow RC, Rahimian A, Huo D, et al
    A randomized trial comparing standard outcomes in two treatment models for substance users with tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:326-32.
    PubMed     Text format     Abstract available


  477. HUANG FL, Jin JL, Chen S, Zhou Z, et al
    MTBDRplus results correlate with treatment outcome in previously treated tuberculosis patients.
    Int J Tuberc Lung Dis. 2015;19:319-25.
    PubMed     Text format     Abstract available


  478. UCHIMURA K, Ngamvithayapong-Yanai J, Kawatsu L, Ohkado A, et al
    Permanent employment or public assistance may increase tuberculosis survival among working-age patients in Japan.
    Int J Tuberc Lung Dis. 2015;19:312-8.
    PubMed     Text format     Abstract available


  479. HSIA NY, Ho YH, Shen TC, Lin CL, et al
    Risk of cataract for people with tuberculosis: results from a population-based cohort study.
    Int J Tuberc Lung Dis. 2015;19:305-11.
    PubMed     Text format     Abstract available


  480. MAVE V, Chandanwale A, Bhosale R, Shere D, et al
    Vitamin D deficiency and risk of postpartum tuberculosis among HIV-infected breastfeeding mothers in India.
    Int J Tuberc Lung Dis. 2015;19:302-4.
    PubMed     Text format     Abstract available


  481. UKWAJA KN, Oshi SN, Alobu I, Oshi DC, et al
    Six- vs. eight-month anti-tuberculosis regimen for pulmonary tuberculosis under programme conditions.
    Int J Tuberc Lung Dis. 2015;19:295-301.
    PubMed     Text format     Abstract available


  482. AVILOV KK, Romanyukha AA, Borisov SE, Belilovsky EM, et al
    An approach to estimating tuberculosis incidence and case detection rate from routine notification data.
    Int J Tuberc Lung Dis. 2015;19:288-94.
    PubMed     Text format     Abstract available


  483. PENZ E, Boffa J, Roberts DJ, Fisher D, et al
    Diagnostic accuracy of the Xpert((R)) MTB/RIF assay for extra-pulmonary tuberculosis: a meta-analysis.
    Int J Tuberc Lung Dis. 2015;19:278-84.
    PubMed     Text format     Abstract available


  484. FAIR E, Miller CR, Ottmani SE, Fox GJ, et al
    Tuberculosis contact investigation in low- and middle-income countries: standardized definitions and indicators.
    Int J Tuberc Lung Dis. 2015;19:269-72.
    PubMed     Text format     Abstract available


  485. DANIEL TM
    Jean-Antoine Villemin and the infectious nature of tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:267-8.
    PubMed     Text format    


  486. VILLEMIN DJ
    On the virulence and specificity of tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:256-66.
    PubMed     Text format    


  487. HOUBEN RM, White RG
    To improve our tuberculosis burden estimates we need to learn from each other.
    Int J Tuberc Lung Dis. 2015;19:255.
    PubMed     Text format    


  488. O'GRADY J, Kik SV, Ferrara G
    Extra-pulmonary tuberculosis and Xpert((R)) MTB/RIF: all about meta-analyses?
    Int J Tuberc Lung Dis. 2015;19:254.
    PubMed     Text format    


  489. STEINGART KR, Schiller I, Dendukuri N
    In reply to 'False-positive Xpert(R) MTB/RIF assays in previously treated patients'.
    Int J Tuberc Lung Dis. 2015;19:366-7.
    PubMed     Text format    


  490. HOGER S, Lykens K, Beavers S, Katz D, et al
    In reply.
    Int J Tuberc Lung Dis. 2015;19:367-8.
    PubMed     Text format    


  491. ZHANG H, Zhang JQ, Zhong XN, Liu GN, et al
    Two case reports of Castleman disease with pulmonary involvement.
    Int J Tuberc Lung Dis. 2015;19:362-5.
    PubMed     Text format     Abstract available


  492. PARK SJ, Jo KW, Yoo B, Lee CK, et al
    Comparison of LTBI treatment regimens for patients receiving anti-tumour necrosis factor therapy.
    Int J Tuberc Lung Dis. 2015;19:342-8.
    PubMed     Text format     Abstract available


  493. WANG HF, Wang R, O'Gorman M, Crownover P, et al
    Bioequivalence of fixed-dose combination RIN(R)-150 to each reference drug in loose combination.
    Int J Tuberc Lung Dis. 2015;19:333-8.
    PubMed     Text format     Abstract available


  494. MOYENGA I, Roggi A, Sulis G, Diande S, et al
    The impact of Xpert(R) MTB/RIF depends on service coordination: experience in Burkina Faso.
    Int J Tuberc Lung Dis. 2015;19:285-7.
    PubMed     Text format     Abstract available


  495. BOYLES TH, Thwaites GE
    Appropriate use of the Xpert(R) MTB/RIF assay in suspected tuberculous meningitis.
    Int J Tuberc Lung Dis. 2015;19:276-7.
    PubMed     Text format     Abstract available


  496. LIPPINCOTT CK, Miller MB, Van Rie A, Weber DJ, et al
    The complexities of Xpert(R) MTB/RIF interpretation.
    Int J Tuberc Lung Dis. 2015;19:273-5.
    PubMed     Text format     Abstract available


  497. RIEDER HL
    Jean-Antoine Villemin: ending an Alpine divide.
    Int J Tuberc Lung Dis. 2015;19:253.
    PubMed     Text format    


    February 2015
  498. DESHMUKH R
    Breaking down barriers to adherence to standards of tuberculosis care.
    Int J Tuberc Lung Dis. 2015;19:251.
    PubMed     Text format    


  499. KONSTANTINOS A
    Mass treatment to eliminate tuberculosis from an island population.
    Int J Tuberc Lung Dis. 2015;19:251-2.
    PubMed     Text format    


  500. SAFDAR N, Zahid R, Shah S, Fatima R, et al
    Tuberculosis patients learning about second-hand smoke (TBLASS): results of a pilot randomised controlled trial.
    Int J Tuberc Lung Dis. 2015;19:237-43.
    PubMed     Text format     Abstract available


  501. EVANS TB, Mador MJ, Glick M, Ahmad I, et al
    Tuberculosis misclassification among resettled refugees in Buffalo, New York, USA.
    Int J Tuberc Lung Dis. 2015;19:231-6.
    PubMed     Text format     Abstract available


  502. GAO XF, Rao Y
    Quality of life of a migrant population with tuberculosis in West China.
    Int J Tuberc Lung Dis. 2015;19:223-30.
    PubMed     Text format     Abstract available



  503. Market assessment of tuberculosis diagnostics in South Africa, 2012-2013.
    Int J Tuberc Lung Dis. 2015;19:216-22.
    PubMed     Text format     Abstract available


  504. MAH A, Kharrat H, Ahmed R, Gao Z, et al
    Serum drug concentrations of INH and RMP predict 2-month sputum culture results in tuberculosis patients.
    Int J Tuberc Lung Dis. 2015;19:210-5.
    PubMed     Text format     Abstract available


  505. MECHAI F, Figoni J, Wyplosz B, Aoun O, et al
    Survey of French physician practices in treatment and control of transmission of smear-positive tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:205-9.
    PubMed     Text format     Abstract available


  506. LEE K, Chung W, Jung Y, Kim Y, et al
    CXCR3 ligands as clinical markers for pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2015;19:191-9.
    PubMed     Text format     Abstract available


  507. VAN DEUN A, Aung KJ, Hossain A, de Rijk P, et al
    Disputed rpoB mutations can frequently cause important rifampicin resistance among new tuberculosis patients.
    Int J Tuberc Lung Dis. 2015;19:185-90.
    PubMed     Text format     Abstract available


  508. AKHMETOVA A, Kozhamkulov U, Bismilda V, Chingissova L, et al
    Mutations in the pncA and rpsA genes among 77 Mycobacterium tuberculosis isolates in Kazakhstan.
    Int J Tuberc Lung Dis. 2015;19:179-84.
    PubMed     Text format     Abstract available


  509. SINANOVIC E, Ramma L, Vassall A, Azevedo V, et al
    Impact of reduced hospitalisation on the cost of treatment for drug-resistant tuberculosis in South Africa.
    Int J Tuberc Lung Dis. 2015;19:172-8.
    PubMed     Text format     Abstract available



  510. Nationwide survey of anti-tuberculosis drug resistance in Japan.
    Int J Tuberc Lung Dis. 2015;19:157-62.
    PubMed     Text format     Abstract available


  511. KAMAL SM, Hossain A, Sultana S, Begum V, et al
    Anti-tuberculosis drug resistance in Bangladesh: reflections from the first nationwide survey.
    Int J Tuberc Lung Dis. 2015;19:151-6.
    PubMed     Text format     Abstract available


  512. CRANMER LM, Kanyugo M, Lohman-Payne B, Tapia K, et al
    Tuberculosis interferon-gamma responses in the breast milk of human immunodeficiency virus infected mothers.
    Int J Tuberc Lung Dis. 2015;19:141-3.
    PubMed     Text format     Abstract available


  513. ANDREWS JR, Stout JE
    Treating multidrug-resistant tuberculosis in community settings: a wise investment.
    Int J Tuberc Lung Dis. 2015;19:127.
    PubMed     Text format    


  514. SOLOMONS RS, Goussard P, Visser DH, Marais BJ, et al
    Chest radiograph findings in children with tuberculous meningitis.
    Int J Tuberc Lung Dis. 2015;19:200-4.
    PubMed     Text format     Abstract available


  515. LOVEDAY M, Wallengren K, Brust J, Roberts J, et al
    Community-based care vs. centralised hospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa.
    Int J Tuberc Lung Dis. 2015;19:163-71.
    PubMed     Text format     Abstract available


  516. COLEMAN M, Finney LJ, Komrower D, Chitani A, et al
    Markers to differentiate between Kaposi's sarcoma and tuberculous pleural effusions in HIV-positive patients.
    Int J Tuberc Lung Dis. 2015;19:144-50.
    PubMed     Text format     Abstract available


  517. DENHOLM JT, Matteelli A, Reis A
    Latent tuberculous infection: ethical considerations in formulating public health policy.
    Int J Tuberc Lung Dis. 2015;19:137-40.
    PubMed     Text format     Abstract available


    January 2015
  518. YAMANA H, Matsui H, Fushimi K, Yasunaga H, et al
    Treatment options and outcomes of hospitalised tuberculosis patients: a nationwide study.
    Int J Tuberc Lung Dis. 2015;19:120-6.
    PubMed     Text format     Abstract available


  519. VOLKMANN T, Moonan PK, Miramontes R, Oeltmann JE, et al
    Tuberculosis and excess alcohol use in the United States, 1997-2012.
    Int J Tuberc Lung Dis. 2015;19:111-9.
    PubMed     Text format     Abstract available


  520. MCLAREN ZM, Brouwer E, Ederer D, Fischer K, et al
    Gender patterns of tuberculosis testing and disease in South Africa.
    Int J Tuberc Lung Dis. 2015;19:104-10.
    PubMed     Text format     Abstract available


  521. LORENT N, Buyze J, Kim T, Kong C, et al
    Is frontloaded sputum microscopy an option in active tuberculosis case finding?
    Int J Tuberc Lung Dis. 2015;19:91-6.
    PubMed     Text format     Abstract available


  522. KIM YW, Kwak N, Seong MW, Kim EC, et al
    Accuracy of the Xpert((R)) MTB/RIF assay for the diagnosis of extra-pulmonary tuberculosis in South Korea.
    Int J Tuberc Lung Dis. 2015;19:81-6.
    PubMed     Text format     Abstract available


  523. OLARU ID, Rachow A, Lange C, Ntinginya NE, et al
    Ascertaining in vivo virulence of Mycobacterium tuberculosis lineages in patients in Mbeya, Tanzania.
    Int J Tuberc Lung Dis. 2015;19:70-3.
    PubMed     Text format     Abstract available


  524. ARNEDO-PENA A, Juan-Cerdan JV, Romeu-Garcia A, Garcia-Ferrer D, et al
    Vitamin D status and incidence of tuberculosis among contacts of pulmonary tuberculosis patients.
    Int J Tuberc Lung Dis. 2015;19:65-9.
    PubMed     Text format     Abstract available


  525. FAN WC, Liu CJ, Hong YC, Feng JY, et al
    Long-term risk of tuberculosis in haematopoietic stem cell transplant recipients: a 10-year nationwide study.
    Int J Tuberc Lung Dis. 2015;19:58-64.
    PubMed     Text format     Abstract available


  526. COLLINS SE, Jean Juste MA, Koenig SP, Secours R, et al
    CD4 deficit and tuberculosis risk persist with delayed antiretroviral therapy: 5-year data from CIPRA HT-001.
    Int J Tuberc Lung Dis. 2015;19:50-7.
    PubMed     Text format     Abstract available


  527. BROUWER M, Coelho E, das Dores Mosse C, van Leth F, et al
    Implementation of tuberculosis infection prevention and control in Mozambican health care facilities.
    Int J Tuberc Lung Dis. 2015;19:44-9.
    PubMed     Text format     Abstract available


  528. REID A, Grant AD, White RG, Dye C, et al
    Accelerating progress towards tuberculosis elimination: the need for combination treatment and prevention.
    Int J Tuberc Lung Dis. 2015;19:5-9.
    PubMed     Text format     Abstract available


  529. LAWN SD
    Preventing HIV-associated tuberculosis with antiretroviral therapy: shut the stable door early!
    Int J Tuberc Lung Dis. 2015;19:3-4.
    PubMed     Text format    


  530. SCHUMACHER SG, Pai M
    Xpert((R)) MTB/RIF for extra-pulmonary tuberculosis: time to look beyond accuracy.
    Int J Tuberc Lung Dis. 2015;19:2.
    PubMed     Text format    


  531. ZISHIRI V, Chihota V, McCarthy K, Charalambous S, et al
    Pooling sputum from multiple individuals for Xpert(R) MTB/RIF testing: a strategy for screening high-risk populations.
    Int J Tuberc Lung Dis. 2015;19:87-90.
    PubMed     Text format     Abstract available


  532. SOLOMONS RS, Visser DH, Friedrich SO, Diacon AH, et al
    Improved diagnosis of childhood tuberculous meningitis using more than one nucleic acid amplification test.
    Int J Tuberc Lung Dis. 2015;19:74-80.
    PubMed     Text format     Abstract available


  533. YUEN CM, Krapivina TM, Kazennyy BY, Kiryanova EV, et al
    Annual risk of tuberculous infection measured using serial skin testing, Orel Oblast, Russia, 1991-2005.
    Int J Tuberc Lung Dis. 2015;19:39-43.
    PubMed     Text format     Abstract available


  534. HIRSCH-MOVERMAN Y, Shrestha-Kuwahara R, Bethel J, Blumberg HM, et al
    Latent tuberculous infection in the United States and Canada: who completes treatment and why?
    Int J Tuberc Lung Dis. 2015;19:31-8.
    PubMed     Text format     Abstract available


    December 2014
  535. SHARMA P, Sharma K, Singh D, Verma S, et al
    Failure of the MGIT(TM) 960 culture system in the detection of Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2014;18:1525.
    PubMed     Text format    


  536. ATRE S
    Private players in tuberculosis control: will negotiation help to maintain the symbiosis in the ecosystem?
    Int J Tuberc Lung Dis. 2014;18:1524-6.
    PubMed     Text format    


  537. ADADA H, Valley MA, Nour SA, Mehta J, et al
    Epidemiology of extra-pulmonary tuberculosis in the United States: high rates persist in the post-HIV era.
    Int J Tuberc Lung Dis. 2014;18:1516-21.
    PubMed     Text format     Abstract available


  538. LOPES MA, Ferracioli KR, Siqueira VL, de Lima Scodro RB, et al
    In vitro interaction of eupomatenoid-5 from Piper solmsianum C. DC. var. solmsianum and anti-tuberculosis drugs.
    Int J Tuberc Lung Dis. 2014;18:1513-5.
    PubMed     Text format     Abstract available


  539. BISHARA H, Rorman E, Mor Z, Shechter-Amram D, et al
    Tuberculosis Beijing strain outbreak in an Israeli Arab rural community linked to an incarcerated immigrant.
    Int J Tuberc Lung Dis. 2014;18:1502-4.
    PubMed     Text format     Abstract available


  540. LIU F, Du FJ, Jia HY, Pan LP, et al
    Inadequate values from an interferon-gamma release assay for smear-negative tuberculosis in a high-burden setting.
    Int J Tuberc Lung Dis. 2014;18:1496-501.
    PubMed     Text format     Abstract available


  541. CHADHA VK, Praseeja P, Hemanthkumar NK, Shivshankara BA, et al
    Are registered sputum smear-negative tuberculosis patients in Karnataka, India, diagnosed by national algorithm?
    Int J Tuberc Lung Dis. 2014;18:1491-5.
    PubMed     Text format     Abstract available


  542. WU YC, Lo HY, Yang SL, Chou P, et al
    Factors correlated with tuberculosis reported after death.
    Int J Tuberc Lung Dis. 2014;18:1485-90.
    PubMed     Text format     Abstract available


  543. FURIN J, Isaakidis P, Reid AJ, Kielmann K, et al
    'I'm fed up': experiences of prior anti-tuberculosis treatment in patients with drug-resistant tuberculosis and HIV.
    Int J Tuberc Lung Dis. 2014;18:1479-84.
    PubMed     Text format     Abstract available


  544. PACHECO AG, Veloso VG, Nunes EP, Ribeiro S, et al
    Tuberculosis is associated with non-tuberculosis-related deaths among HIV/AIDS patients in Rio de Janeiro.
    Int J Tuberc Lung Dis. 2014;18:1473-8.
    PubMed     Text format     Abstract available


  545. KANCHEYA N, Luhanga D, Harris JB, Morse J, et al
    Integrating active tuberculosis case finding in antenatal services in Zambia.
    Int J Tuberc Lung Dis. 2014;18:1466-72.
    PubMed     Text format     Abstract available


  546. JIMENEZ-FUENTES MA, Auge CM, Gomez MN, Peiro JS, et al
    Screening for active tuberculosis in high-risk groups.
    Int J Tuberc Lung Dis. 2014;18:1459-65.
    PubMed     Text format     Abstract available


  547. CHADHA VK, Praseeja P, Gupta J, Ahmed J, et al
    A descriptive study of tuberculosis case finding in private health care facilities in a South Indian district.
    Int J Tuberc Lung Dis. 2014;18:1455-8.
    PubMed     Text format     Abstract available


  548. RUBINOWICZ A, Bartlett G, MacGibbon B, Greenaway C, et al
    Evaluating the role of primary care physicians in the treatment of latent tuberculosis: a population study.
    Int J Tuberc Lung Dis. 2014;18:1449-54.
    PubMed     Text format     Abstract available


  549. AZADI M, Bishai DM, Dowdy DW, Moulton LH, et al
    Cost-effectiveness of tuberculosis screening and isoniazid treatment in the TB/HIV in Rio (THRio) Study.
    Int J Tuberc Lung Dis. 2014;18:1443-8.
    PubMed     Text format     Abstract available


  550. CAMPBELL IA, Chaudhary RD, Holdsworth GM, Lyne OD, et al
    Brief advice to tuberculosis patients in Nepal to stop smoking: a pilot study by the Britain Nepal Medical Trust.
    Int J Tuberc Lung Dis. 2014;18:1438-42.
    PubMed     Text format     Abstract available


  551. KOHLER S, Asadov DA, Brunder A, Healy S, et al
    Ambulatory tuberculosis treatment in post-Semashko health care systems needs supportive financing mechanisms.
    Int J Tuberc Lung Dis. 2014;18:1390-5.
    PubMed     Text format     Abstract available


  552. SOTGIU G, Gegia M, Migliori GB
    Extra-pulmonary tuberculosis: the comorbidity of the near future?
    Int J Tuberc Lung Dis. 2014;18:1389.
    PubMed     Text format    


    November 2014
  553. FRICK M, Seaworth B, McKenna L, Elnour T, et al
    Cost-effectiveness of 12-dose LTBI regimen improved following advocacy to lower the price of rifapentine.
    Int J Tuberc Lung Dis. 2014;18:1386.
    PubMed     Text format    


    August 2014
  554. MARTINSON NA, McLeod KE, Milovanovic M, Msandiwa R, et al
    Implementation of isoniazid preventive therapy for HIV-infected adults: overstatement of district reports.
    Int J Tuberc Lung Dis. 2014;18:1005.
    PubMed     Text format    


  555. SANTUCCI N, Diaz A, Bianchi E, Spinelli S, et al
    Leptin does not enhance cell-mediated immune responses following mycobacterial antigen stimulation.
    Int J Tuberc Lung Dis. 2014;18:981-7.
    PubMed     Text format     Abstract available


  556. MAREKOVIC I, Bosnjak Z, Plecko V
    Direct identification of mycobacteria from smear-positive samples using real-time polymerase chain reaction.
    Int J Tuberc Lung Dis. 2014;18:978-80.
    PubMed     Text format     Abstract available


  557. SHIVARAMAKRISHNA HR, Frederick A, Shazia A, Murali L, et al
    Isoniazid preventive treatment in children in two districts of South India: does practice follow policy?
    Int J Tuberc Lung Dis. 2014;18:919-24.
    PubMed     Text format     Abstract available


  558. BAMRAH S, Brostrom R, Dorina F, Setik L, et al
    Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009-2012.
    Int J Tuberc Lung Dis. 2014;18:912-8.
    PubMed     Text format     Abstract available


  559. BONFIGLIOLI KR, Ribeiro AC, Moraes JC, Saad CG, et al
    LTBI screening in rheumatoid arthritis patients prior to anti-TNF treatment in an endemic area.
    Int J Tuberc Lung Dis. 2014;18:905-11.
    PubMed     Text format     Abstract available


    July 2014
  560. BOYLES TH, Hughes J, Cox V, Burton R, et al
    False-positive Xpert(R) MTB/RIF assays in previously treated patients: need for caution in interpreting results.
    Int J Tuberc Lung Dis. 2014;18:876-8.
    PubMed     Text format     Abstract available


  561. BANSAL AK, Kulshrestha N, Nagaraja SB, Rade K, et al
    Composite indicator: new tool for monitoring RNTCP performance in India.
    Int J Tuberc Lung Dis. 2014;18:840-2.
    PubMed     Text format     Abstract available


  562. CARUGATI M, Schiroli C, Zanini F, Vanoni N, et al
    A new predictive model for an improved respiratory isolation strategy in HIV-infected patients with PTB.
    Int J Tuberc Lung Dis. 2014;18:831-6.
    PubMed     Text format     Abstract available


  563. SCHWARTZ IS, Bach PJ, Roscoe B, Majury A, et al
    Interferon-gamma release assays piloted as a latent tuberculous infection screening tool in Canadian federal inmates.
    Int J Tuberc Lung Dis. 2014;18:787-92.
    PubMed     Text format     Abstract available


  564. RIEDER HL
    Ninety years after The Magic Mountain: world literature inspired by a misdiagnosis, a tribute to Christian Virchow.
    Int J Tuberc Lung Dis. 2014;18:761-2.
    PubMed     Text format    


    June 2014
  565. CRUZ-FERRO E, Ursua-Diaz MI, Taboada-Rodriguez JA, Hervada-Vidal X, et al
    In reply.
    Int J Tuberc Lung Dis. 2014;18:752-3.
    PubMed     Text format    


  566. SHEPARDSON D, MacKenzie WR
    Update on cost-effectiveness of a 12-dose regimen for latent tuberculous infection at new rifapentine prices.
    Int J Tuberc Lung Dis. 2014;18:751.
    PubMed     Text format    


  567. KIM YK, Hahn S, Uh Y, Im DJ, et al
    Comparable characteristics of tuberculous and non-tuberculous mycobacterial cavitary lung diseases.
    Int J Tuberc Lung Dis. 2014;18:725-9.
    PubMed     Text format     Abstract available


  568. AICHELBURG MC, Mandorfer M, Tittes J, Breitenecker F, et al
    The association of smoking with IGRA and TST results in HIV-1-infected subjects.
    Int J Tuberc Lung Dis. 2014;18:709-16.
    PubMed     Text format     Abstract available


  569. SHIBOSKI CH, Chen H, Ghannoum MA, Komarow L, et al
    Role of oral candidiasis in TB and HIV co-infection: AIDS Clinical Trial Group Protocol A5253.
    Int J Tuberc Lung Dis. 2014;18:682-8.
    PubMed     Text format     Abstract available


    May 2014
  570. PUTRI FA, Burhan E, Nawas A, Soepandi PZ, et al
    Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
    Int J Tuberc Lung Dis. 2014;18:564-70.
    PubMed     Text format     Abstract available


  571. AMLABU V, Mulligan C, Jele N, Evans A, et al
    Isoniazid/acetylisoniazid urine concentrations: markers of adherence to isoniazid preventive therapy in children.
    Int J Tuberc Lung Dis. 2014;18:528-30.
    PubMed     Text format     Abstract available


  572. LANIADO-LABORIN R, Cazares-Adame R, Volker-Soberanes ML, del Portillo-Mustieles C, et al
    Latent tuberculous infection prevalence among paediatric contacts of drug-resistant and drug-susceptible cases.
    Int J Tuberc Lung Dis. 2014;18:515-9.
    PubMed     Text format     Abstract available


    April 2014
  573. KALITA J, Prasad S, Misra UK
    Predictors of paradoxical tuberculoma in tuberculous meningitis.
    Int J Tuberc Lung Dis. 2014;18:486-91.
    PubMed     Text format     Abstract available


  574. HUANG ZK, Luo Q, Xiong GL, Li WT, et al
    Evaluation of indirect drug susceptibility testing using the MODS assay for the detection of XDR-TB in China.
    Int J Tuberc Lung Dis. 2014;18:461-5.
    PubMed     Text format     Abstract available


  575. PAGE-SHIPP L, Stevens W, Clark D, Scott L, et al
    Successes, challenges and lessons from a novel deployment of Xpert((R)) MTB/RIF at a major South African public event [Short Communication].
    Int J Tuberc Lung Dis. 2014;18:438-40.
    PubMed     Text format     Abstract available


  576. JUNG YJ, Lee JY, Jo KW, Yoo B, et al
    The 'either test positive' strategy for latent tuberculous infection before anti-tumour necrosis factor treatment.
    Int J Tuberc Lung Dis. 2014;18:428-34.
    PubMed     Text format     Abstract available


  577. FISKE CT, Yan FX, Hirsch-Moverman Y, Sterling TR, et al
    Risk factors for treatment default in close contacts with latent tuberculous infection.
    Int J Tuberc Lung Dis. 2014;18:421-7.
    PubMed     Text format     Abstract available


  578. ERKENS CG, Dinmohamed AG, Kamphorst M, Toumanian S, et al
    Added value of interferon-gamma release assays in screening for tuberculous infection in the Netherlands.
    Int J Tuberc Lung Dis. 2014;18:413-20.
    PubMed     Text format     Abstract available


  579. LALA SG, Parbhoo KB, Verwey C, Khan R, et al
    The effect of topical calcipotriol or zinc on tuberculin skin tests in hospitalised South African children.
    Int J Tuberc Lung Dis. 2014;18:388-93.
    PubMed     Text format     Abstract available


  580. WHITE RG, Houben RM
    Towards elimination in industrialised countries: expanding diagnosis and treatment of LTBI among immigrants.
    Int J Tuberc Lung Dis. 2014;18:380.
    PubMed     Text format    


  581. VAN LETH F, Kampmann B
    Embracing the challenges of HIV-TB co-infection in children.
    Int J Tuberc Lung Dis. 2014;18:379.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: